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ABSTRACT 
 
This study proposed to examine the impact of substance use and abuse on the 
treatment and coping mechanisms of generalized anxiety disorder (GAD) in African 
American women. Comorbid mental health problems such as depression and anxiety are 
common in individuals with alcohol and other drug problems. The co-occurrence of 
substance use disorders (SUDs) and anxiety disorders has now been well documented 
(Vorspan, Mehtelli, Dupuy, Bloch, & Lépine, 2015). 
Research has shown that up to 80% of clients with alcohol or drug issues have 
comorbid mental health issues. However, little is known about the occurrence of this 
association in African American women. The findings of this research would have great 
implications for treatment and prevention in this underserved population. 
The approach to data analysis involved two levels of examination: 1) univariate 
statistics (descriptive statistics will be used to provide simple summaries about the 
sample and all of the study measures) and 2) bivariate analysis for descriptive purposes 
(depending on the variable type), correlations, and survival analysis were performed to 
document the association between the independent variables and outcome variables. 
The present study examined the link between mental (anxiety disorders and the 
severity of anxiety symptoms) and drug use disorders in a sample of African American 
females (N = 537, aged 19 to 56 years old). Preliminary analysis indicated that only high 
(and not low or moderate) perceived family support was shown to be a protective factor 
in terms of the mixed-effects regression analysis of GAD as well as the severity of 
anxiety/fear symptoms. Additionally, the following factors proved to be significant in 
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increasing the likelihood of GAD prevalence or having more severe anxiety/fear 
symptoms: being dually diagnosed across all models, some level of moderate to severe 
drug and alcohol composite scores, criminal justice charges, and having some type of 
insurance that did not include Medicaid. Findings from the current study are discussed in 
terms of their implications for prevention and treatment of comorbid drug use and mental 
health disorders among minority populations. 
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CHAPTER 1 
INTRODUCTION 
 
Anxiety does not empty tomorrow of its sorrows,  
but only empties today of its strength. 
— Charles Haddon Spurgeon  
 
INTRODUCTION AND BACKGROUND 
Substance use and mental health disorders can greatly affect the health of 
individuals, as well as their families and their communities. In 2014, almost 1 in 5 adults 
aged 18 or older (18.1%, or 43.6 million adults) reported to the National Survey on Drug 
Use and Health (NSDUH) that they had any mental illness in the preceding year. 
Additionally, 21.5 million people aged 12 or older reported a substance use disorder in 
the preceding year (Center for Behavioral Health Statistics and Quality, 2015). Both 
substance use and mental health disorders “are among the top conditions that cause 
disability and can carry a high burden of the disease, resulting in significant costs to 
families, employers, and publicly funded health systems” (Substance Abuse and Mental 
Health Services Administration [SAMHSA], 2004). According to SAMHSA (2004), “By 
2020, mental disorders and substance use disorders will surpass all physical diseases as a 
major cause of disability worldwide.” The coexistence of both a mental health issue and a 
substance use disorder is referred to as a co-occurring disorder.   
The co-occurrence of substance use disorders and anxiety disorders has now been 
well documented (Vorspan, Mehtelli, Dupuy, Bloch, & Lépine, 2015; Chilcoat & 
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Breslau, 1998b; Drake, Mueser, & Brunette, 2007). In most instances, knowledge on the 
association between anxiety and substance use disorders can be drawn from clinical 
studies among patients in treatment either for anxiety disorders or for substance use 
disorders (Drake, Mueser, & Brunette, 2007; Himle, Baser, Taylor, Campbell, & Jackson, 
2009). Despite the fact that much is known about generalized anxiety disorder (GAD) 
and substance abuse disorders separately, little has been discussed as to the potential 
reasons such large percentages of GAD sufferers also present with substance abuse 
disorder (National Institutes of Mental Health, 2013; SAMHSA, 1999). Previous research 
into comorbidity has often been limited to descriptions of the comorbid patterns (Chilcoat 
& Breslau, 1998b) or controlling for comorbidity among multiple disorders (Chilcoat & 
Breslau, 1998a). This approach does not provide complete information on the 
implications of comorbidity and the risk for developing drug use disorders. It is important 
to study the potential causal relationship between the two disorders because it will lead to 
effective treatment of each disorder and potentially preventative measures. Since these 
disorders can appear very similar, it is important to be able to distinguish between the two 
and to determine whether one is actually the symptom of the other.  
Individuals suffering from some type of mental health condition are also more 
likely to use alcohol or drugs than those not affected by a mental illness (Kessler et al., 
1996; SAMHSA, 1999). Additionally, research on adult clinical samples has shown that 
the presence of mental disorders increases an individual’s risk for developing a drug use 
disorder (Kessler et al., 1996). The association of mental illness with substance-related 
disorders has been well established in both clinical studies and in population-based 
studies (Drake, Mueser, & Brunette, 2007; Himle, Baser, Taylor, Campbell, & Jackson, 
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2009). Previous studies that have reported this association have often not taken into 
account earlier substance use and its relationship to developing anxiety (Himle et al., 
2009). According to Drake, Mueser, and Brunette, 
Lifetime prevalence rates of alcohol and drug use disorders are approximately 
17% in the general population (those without mental health disorders); 55% for 
people with bipolar disorder; 47% to 50% for people with schizophrenia; 30% for 
people with other mood or anxiety disorders; 24% to 27% for people with 
posttraumatic stress disorder; 18% to 20% for people with antisocial personality 
disorder; and 17% to 18% for people with borderline personality disorder (2007).  
Even though 30% of those with anxiety disorders will be afflicted with a 
substance abuse disorder in their lifetime, the relationship between substance abuse 
disorder and anxiety disorders still remains unclear. According to Sloboda, Glantz, and 
Tarter (2012), diagnoses of any mental illness, and particularly personality disorders and 
psychotic disorders (which includes generalized anxiety disorder), were found to be 
associated with higher prevalence of transition from substance use to a substance use 
disorder across most categories of substances. In other words, those with these mental 
health disorders were more likely to become dependent on substances, thus moving away 
from infrequent or causal use. In some instances the anxiety disorder precedes the 
substance use and abuse, but that is not always the case. More research is needed to 
determine whether there is really a causal relationship between the two disorders.  
Additionally, research shows that minorities, who suffer from chronic stressors 
such as discrimination, racism, and prejudice, may experience more damaging 
physiological effects. More importantly, these race-specific stressors may contribute to 
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health disparities between minorities and nonminorities in the United States. According 
to SAMHSA (1999), racial and ethnic minorities have less access to mental health 
services than do their Caucasian counterparts. These minorities are also less likely to 
receive needed care for mental illness, and when they do receive treatment, it is more 
likely to be poor in quality (SAMHSA, 1999). Previous studies that have examined the 
link between anxiety disorders and drug use disorders have generally relied on 
predominantly White or Caucasian samples with participants under 60 years old 
(Chilcoat & Breslau, 1998a, 1998b). In studies where both sexes or non-White 
participants have been measured, sex and ethnic variations in risk for drug use disorders 
frequently went unexamined (Williams, Domanico, Marques, Leblanc, & Turkheimer, 
2013; Lopez, Turner, & Saavedra, 2005; Neal-Barnett & Crowther, 2000). Furthermore, 
gender differences exist in the experience of stress and discrimination such that the 
influence of perceived discrimination on depression is greater for women than men 
(Flores et al., 2008). The purpose of this paper is to analyze and discuss the comorbidity 
of generalized anxiety disorder among a sample of African American women who have 
been diagnosed with substance use disorders so as to provide some potential reasons for 
the relationship. 
 
STATEMENT OF THE PROBLEM 
Generalized anxiety disorder is characterized by persistent, excessive, and 
unrealistic worry about everyday things (American Psychiatric Association [APA], 2000; 
Wittchen, 2002; Drake, Mueser, & Brunette, 2007; Kessler, Chiu, Demler, & Walters, 
2005). GAD affects about 6.8 million adults, or 3.1% of the U.S. population, in any given 
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year. Anxiety disorders are a major cause of disability and are associated with increased 
health care service utilization (Sanderson & Andrews, 2002; Kessler, Chiu, Demler, & 
Walters, 2005). Women are twice as likely to be affected. The disorder comes on 
gradually and can begin across the life cycle, though the risk is highest between 
childhood and middle age. Even though the exact cause of GAD is unknown, there is 
some evidence that biological factors, family background, and life experiences, 
particularly stressful ones, play a role (National Institutes of Mental Health, 2013). As 
many as half of all adults with co-occurring disorders have not received treatment for 
either diagnosis. A national survey conducted in 2004 found that 50% of adults known to 
have comorbid mental illness and substance use disorder did not receive treatment for 
either condition within the preceding year (McGovern, Xie, Segal, Siembab, & Drake, 
2006). Those who did not receive treatment for either illness may experience additional 
consequences. These consequences can include more severe symptoms regarding the 
mental illness, frequent relapses, hospitalizations, homelessness, violence, incarceration, 
or worse health outcomes, including serious infections associated with drug use such as 
HIV and hepatitis (Drake et al., 2007). It is thus necessary to conduct a study that 
explores the comorbidity of generalized anxiety disorder and substance abuse disorder in 
this underserved group. 
 
PURPOSE OF THE STUDY 
Comorbid mental health problems such as depression or anxiety are common in 
individuals with alcohol and other drug problems. Research on the link between mental 
and drug use disorders often has failed to incorporate individuals of varying sexes, 
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ethnicity, and age, thus limiting the generalizability of the findings (Lopez, Turner, & 
Saavedra, 2005; Kessler et al., 1996). Therefore, little is known about the occurrence of 
this association specifically in African American female substance abusers. This study 
proposed to examine the impact of substance use or abuse on the treatment and coping 
mechanisms of generalized anxiety disorder in African American women. This study also 
aimed to determine whether rates of anxiety decrease if a substance abuser becomes free 
of their addiction. The findings of this research would have great implications for 
treatment and prevention in this population. 
 
RESEARCH QUESTIONS 
The central research question that this study aimed to answer is what happens to 
the comorbidity of anxiety among African American women who have been diagnosed 
with substance use issues as they become free of alcohol and drug use? This study will 
also address the following research sub-questions: 
1. How prevalent is generalized anxiety disorder among African American women 
aged 18+? 
2. What is the relationship between anxiety and drug use in this population?  
3. Are there any differences in the level of education and the relationship between 
substance use/abuse and GAD?  
4. Is one possible motive for the drug use/abuse to alleviate anxiety symptoms?  
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HYPOTHESIS 
Hypothesis #1: As a participant becomes free of substance use disorder (SUD), their rates 
of generalized anxiety disorder (GAD) will increase. 
 
Hypothesis #2: A study participant’s rates of GAD will be inversely related (as one 
decrease the other will increase) to rates of SUD.   
 
Hypothesis #3: Coping skills are moderating factors on the relationship between GAD 
and SUD. 
 
DEFINITION OF TERMS 
Coping strategies are defined as individual efforts to resolve, endure, or alleviate 
problems and experienced stress (Lazarus & Folkman, 1984). 
 
Hard-to-reach population – adults, young people, and children from any ethnic 
background, regardless of migration status. They are “hard to reach” if their social 
circumstances, language, culture, or lifestyle (or those of their parents or caregivers) 
make it difficult to access diagnostic and treatment services, self-administer treatment, or 
attend regular appointments for clinical follow-up (Faugier & Sargeant 1997). 
 
Generalized anxiety disorder – characterized by chronic feelings of excessive worry and 
anxiety without a specific cause. Individuals with generalized anxiety disorder often feel 
on edge, tense, and jittery (APA, 2000). 
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Intolerance of uncertainty (IU) can be defined as a cognitive bias that affects how a 
person perceives, interprets, and responds to uncertain situations. 
 
Negative affectivity is a broad and pervasive predisposition to experience negative 
emotions that has further influences on cognition, self-concept, and worldview (Watson 
& Clark, 1984). 
 
Protective factors – events, conditions, or experiences that reduce, inhibit, or attenuate 
the likelihood of substance use or deviant behaviors to occur (Hawkins, Catalano, & 
Miller, 1992). 
 
Psychiatric comorbidity is defined as the presence, either simultaneously or in 
succession, of two or more specific disorders in an individual within a specified period 
(Wittchen, Perkonigg, & Reed, 1996). 
 
Substance abuse/misuse – the continued misuse of any mind-altering substance that 
severely affects person’s physical and mental health, social situation, and responsibilities. 
A maladaptive pattern of substance use leading to clinically significant impairment or 
distress (APA, 2000). 
 
SIGNIFICANCE OF THE STUDY 
The lack of research on sex, ethnic, or age variations in risk for drug use disorders 
associated with anxiety disorders raises questions about the true generalizability of 
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previous research findings to such populations. This study may prove significant in 
contributing to the underdeveloped area of research related to the comorbidity of anxiety 
disorders and substance abuse in African American women, a population that often does 
not present in mental health treatment clinics. Clinical research trials play a very 
important role in the development of safe and effective treatment methods to treat disease 
and impairment, and thus participation by minorities and women is extremely crucial to 
ensuring the safety and efficacy of new treatments (National Institutes of Mental Health, 
2013). 
In addition, this study will help to pose several pertinent questions to guide future 
research and potential treatment modalities. The relationship between co-occurring 
substance use and other psychiatric disorders may be particularly relevant for women, 
who have both higher overall rates of mood and anxiety disorders and higher rates of co-
occurring substance use and psychiatric disorders relative to men (Kessler, Chiu, Demler, 
& Walters, 2005). Finally, the main significance of this study lies in the fact that no 
existing studies have explored this topic as it relates specifically to African American 
women. 
To summarize, further research is needed to understand African American women 
and their experiences with substance use and generalized anxiety disorder.  
 
OUTLINE OF DISSERTATION 
This dissertation will be divided into six chapters and an appendix. The first 
chapter will provide a brief introduction about generalized anxiety disorder and substance 
abuse, the rationale for the study, statement of the problem, the research questions and 
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hypothesis. Chapter 2 will present a comprehensive review of the literature. The third 
chapter will describe the research methods including how the original dataset was 
created, the forms of data collection, how data will be analyzed, potential ethical issues, 
and the role and background of the issue. In Chapter 4 the results of the data analyses will 
be presented as well as general demographic information. Chapter 5 will provide a 
discussion of these results. The last chapter will discuss the results of the study, future 
research and treatment implications, the strengths and limitations of the study, a 
conclusion, and the references used in all the chapters of this dissertation. The last section 
will include an appendix with a copy of the internal review board approval from the 
University of Illinois at Urbana-Champaign. 
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CHAPTER 2 
LITERATURE REVIEW 
 
An overview is presented of research and other literature with attention to the 
experience of anxiety disorders, substance use disorder and the interaction between the 
two. A computerized search using PubMed was conducted using anxiety, generalized 
anxiety disorder, or GAD with various combinations of the words “addictive disorders” 
OR “SUD” OR “generalized anxiety disorder (GAD)” OR “obsessive compulsive 
disorder (OCD),” “social support system,” and “treatment.” The search was expanded to 
include the keywords “coping mechanism” and “mental illness.” Articles cited within the 
articles identified by the initial PubMed search were also reviewed. The overall search 
was not limited by date of publication but to all relevant literature.  
 
ANXIETY DISORDERS 
Anxiety is a normal reaction to life’s stressors and actually can be beneficial in 
some situations, such as when the feeling of being anxious makes us more alert or more 
aware of our surroundings and therefore better able to respond. Anxiety is an unpleasant 
but normal, functional affect that provides people with warning signs of perceived threats 
(Campbell, 2009; Kessler, Chiu, Demler, & Walters, 2005; Zvolensky, Lejuez, & Eifert, 
2000). Some anxiety is considered a beneficial response in certain dangerous situations 
that trigger the fight-or-flight stress response, a physiological reaction that either prepares 
our bodies to stay and fight or flee the situation (Campbell, 2009). However, for some 
people anxiety can become excessive and debilitating. Anxiety becomes problematic 
  
 
12
when it creates a sense of powerlessness, suggests an impending danger that is 
unrealistic, produces an exhausting state of vigilance, or creates doubt about the nature of 
reality (Campbell, 2009; Kessler, Chiu, Demler, & Walters, 2005). Anxiety disorders, 
which include panic disorder, obsessive-compulsive disorder, posttraumatic stress 
disorder, generalized anxiety disorder, and certain phobias, are collectively the most 
common psychiatric disorders in the U.S. (National Institutes of Mental Health, 2013; 
Campbell, 2009; Kessler, Chiu, Demler, & Walters, 2005). These disorders affect almost 
40 million adults aged 18 or older, or about 18% of the current U.S. population (National 
Institutes of Mental Health, 2013; Campbell, 2009; Kessler, Chiu, Demler, & Walters, 
2005). Anxiety disorders can develop from a variety of risk factors, including genetic 
factors, environmental factors, psychological factors, and developmental factors. It is 
important to note that the exact etiology of anxiety disorder is not fully understood. 
Several theories have been previously proposed in an effort to try to explain the causes of 
anxiety in general. These proposed models for anxiety disorders have generally included 
biological and psychological paradigms (Campbell, 2009; Kessler, Chiu, Demler, & 
Walters, 2005).  
The first of these models includes the psychoanalytic theory (Campbell, 2009). 
This model suggests that anxiety is produced as a result of an unconscious and internal 
conflict, which is specifically said to be between one’s sexual urges and the defenses one 
uses to deal with these urges (Campbell, 2009). This model is highly problematic, often 
scrutinized and considered to be outdated.  
The second theory used to explain the etiology of anxiety disorders is the 
behavioral theory. This theory suggests that feelings of anxiety are a result of learned 
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behaviors through classical conditioning (Starcevic, 2005). John Watson and B. F. 
Skinner suggested the theory that behavior is determined by the environment (e.g., 
through conditioning). For example, once an individual experiences a negative or 
aversive experience, that individual will learn to associate a neutral stimulus with feelings 
of danger or fear. Because of this negative emotional association (even in situations that 
are not dangerous or based in reality), that stimulus will be enough to cause an anxiety 
response (Starcevic, 2005). The anxiety response can become more strongly reinforced if 
that individual avoids the stimulus, never confronting the issue (Starcevic, 2005). This 
avoidance then makes it unlikely that the individual will be able to relearn that the event 
is not threatening (Rapee & Barlow, 2004). It should also be noted that behavioral 
therapy, also known as cognitive behavioral therapy or CBT, is one of the most effective 
treatments for anxiety disorders (Starcevic, 2005). 
The next model used is the cognitive model of anxiety disorders, which focuses 
on an individual’s incorrect assessment of potential danger (Starcevic, 2005). For 
example, it has been demonstrated that anxious individuals are more likely than normal 
(control) subjects to interpret ambiguous situations or environmental stimuli as 
potentially threatening, which they believe could result in potential harm or even death 
(Rapee & Barlow, 2004).  
Genetic and hereditary factors are also deemed to play a significant role in the 
development of anxiety disorders (Rapee & Barlow, 2004). Barlow (2004) summarized 
through family studies that patients with panic disorder and agoraphobia were much more 
likely to have relatives with the disorder than relatives of patients who did not have the 
disorder. Prevalence rates for family members of those with panic disorder or 
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agoraphobia ranged from 7.9% to 41%, while the prevalence rate for the control group 
did not exceed 8%. Additionally, high prevalence rates for family members of patients 
with GAD, OCD, or social and specific phobias have been reported as well (APA, 2000; 
Rapee & Barlow, 2004). Finally, several twin studies have revealed a genetic 
contribution to anxiety, but those results are thought to be confounded by shared 
environmental experiences (Starcevic, 2005). 
Biological factors also may play a role in the development of anxiety disorders. 
Several neurotransmitter systems have been identified as possibly being associated with 
the development of anxiety disorders (Craske, 2003; Craske & Chodhury, 2005). These 
neurotransmitters include gammaaminobutyric acid (GABA), norepinephrine, and 
serotonin. The studies looking into neurotransmitter system changes and abnormalities 
have typically resulted from interest in the effects that certain medications, such as 
benzodiazepines, may have on these systems. Today, benzodiazepines are often 
prescribed to anxiety sufferers (Craske, 2003; Craske & Chodhury, 2005). 
The final model used to explain the etiology of anxiety disorders is that these 
disorders develop as a result of sociocultural factors. A possible link between the 
development of anxiety disorders and sociocultural factors is the role of social 
reinforcement. Social reinforcement influences gender roles beginning in childhood. For 
example, parents typically reinforce male children to be assertive and active and often 
foster their independence. In contrast, female children are frequently encouraged to be 
cautious and less independent, resulting in behavior that is typically more controlled. As 
a result, boys are exposed to a broader range of experiences and tend to be more self-
reliant. Males are also thought to develop more effective coping skills that help to reduce 
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the amount of negative reactivity they experience when exposed to stressful situations 
(Craske, 2003; Craske & Chodhury, 2005).  
Anxiety disorders are highly treatable; however, only about one-third of those 
suffering from them will go on to receive treatment (Kessler et al., 1996). Generalized 
anxiety disorder is just one of the many anxiety disorders outlined in the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV-TR; APA, 2000), the book used by 
qualified mental health professionals to make a diagnosis of generalized anxiety disorder. 
According to the DSM-IV-TR, generalized anxiety disorder is described as excessive 
anxiety and worry occurring more days than not for a period of at least 6 months. Also 
accompanying the primary anxiety and worry are feelings of restlessness, fatigue, 
difficulty concentrating, irritability, muscle tension, disturbed sleep, or a combination of 
these (APA, 2000). The worry must also be seen as pervasive and intrusive on daily 
functioning. A general definition of GAD is also known as “chronic anxiety neurosis” 
and is characterized by chronic anxiety, accompanied by such autonomic symptoms as 
tremors and tachycardia. Commonly, the individual is easily startled and jumpy. Often 
unable to relax, the GAD sufferer may spend restless hours at night trying to fall asleep. 
Those who suffer from GAD often worry about trivial issues or about real issues that 
have been exaggerated or blown of out proportion (Campbell, 2009). Because of the 
excessive nature of their worrying, it is not uncommon for individuals with GAD to have 
difficulty functioning across a wide variety of social situations. The onset of GAD is 
usually in adolescence or in the childhood years; however, it may also first appear in 
early adult years (APA, 2000). Symptoms tend to evolve gradually (APA, 2000; National 
Institutes of Mental Health, 2013). More than half of all individuals who suffer from 
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GAD have reported an onset that began in childhood or adolescence (Campbell, 2009). 
The most common age range for the onset of this disorder is between 15 and 25 years old. 
Onset is usually gradual, and GAD tends to be a chronic condition whose symptoms 
fluctuate over time, with those symptoms typically intensifying during times when a 
person’s life becomes stressful (APA, 2000). For more than half of persons with GAD, or 
almost 67%, there is a co-occurring mental disorder, most typically depressive disorder, 
other anxiety disorders, or substance abuse (Roemer, Orsillo, & Barlow, 2004). 
Currently, there are several models that attempt to explain GAD specifically. 
These models include the avoidance model of worry and GAD (AMW), the intolerance 
of uncertainty model (IUM), the metacognitive model (MCM), the emotion dysregulation 
model (EDM), and finally, the acceptance-based model of generalized anxiety disorder 
(ABM) (Behar, DiMarco, Hekler, Mohlman, & Staples, 2009). All of these current 
models tend to highlight avoidance of internal experiences (Behar, DiMarco, Hekler, 
Mohlman, & Staples, 2009). The model that seems to most fit GAD and current treatment 
strategies is the avoidance model of worry and GAD (AMW). The AMW model suggests 
that cognitive avoidance, ineffective problem-solving behaviors, interpersonal issues, and 
previous trauma account for GAD in certain individuals (Behar, DiMarco, Hekler, 
Mohlman, & Staples, 2009). This model attempts to explain GAD by stating that 
ineffective cognitive attempts to problem-solve a perceived threat are the causes of the 
subject’s anxiety. Otherwise stated, the worry functions as a cognitive avoidance 
response to perceived future threats (Borkovec, Lyonfields, Wiser, & Deihl, 1993). The 
AMW is characterized by theories of cognitive avoidance, emotional avoidance, the 
intolerance of uncertainty, and negative cognitive reactions to emotions. All of these 
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principles are then combined with positive beliefs about worry while the individual is 
also concerned about effects of worry (Behar, DiMarco, Hekler, Mohlman, & Staples, 
2009).  
The two central themes of the AMW are that worrying in itself is a cognitive 
attempt to generate ways to prevent bad events from happening or to prepare oneself for 
their occurrence (Borkovec & Costello, 1993). The second main idea is that worry 
occurring just prior to fear-inducing images mutes aspects of somatic response to the 
stimuli (Borkovec & Costello, 1993).  
Additionally, the majority of investigations examining the five models have 
employed nonexperimental designs in tests of hypotheses. This fact stands in stark 
contrast to the various specific causal hypotheses presented by the models. Despite these 
limitations, the models collectively offer valuable insights into the basic nature of GAD 
and the necessary steps to its successful treatment. The five theoretical models share a 
common emphasis on the central importance of avoidance of internal experiences. 
Further, there are several common treatment components across the models, including 
psychoeducation about GAD, self-monitoring, and an emphasis on training clients to 
cope with internal experiences. Although significant advances have been made in the 
theoretical understanding of GAD, there remains a need for a greater amount of basic 
research examining the predictive components of the five models. Moreover, additional 
randomized clinical trials are warranted to further test the practical utility of each model 
and its impact on individuals suffering from GAD. 
As stated previously, the lifetime prevalence of generalized anxiety disorder has 
been estimated as affecting 6.8 million adults, or about 3.1% of the U.S. population. 
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Women are twice as likely to be affected by GAD as men. Lifetime prevalence rates of 
anxiety are estimated to be higher than any other class of psychological disorder (Kessler, 
Chiu, Demler, & Walters, 2005), and women are estimated to be affected by anxiety 
disorders more than men, with some estimates as large as 2:1 (Craske, 2003). Despite 
clear evidence of gender differences in rates of anxiety disorders, gender has not been 
consistently assessed in the development and maintenance of anxiety disorders 
specifically in women. 
 
ANXIETY DISORDERS IN WOMEN 
 Lifetime prevalence rates for anxiety disorders in women are estimated to be 
30.5%, and 22.6% for any given 12-month period (Barlow, 2001). From the time a 
woman reaches puberty until about the age of 50, she is twice as likely to have an anxiety 
disorder as a man. Anxiety disorders also occur earlier in women than in men. Women 
are also more likely to have multiple psychiatric disorders during their lifetime than men. 
The most common to co-occur with anxiety is depression. While it has been clearly 
evidenced that women suffer from anxiety disorders more than men, the reasons for these 
research findings are not quite clear. Differences in brain chemistry may account for at 
least part of these differences (Craske, 2003; Craske & Chowdhury, 2005). The brain 
system involved in the fight-or-flight response is activated more readily in women and 
stays activated longer than in men, partly as a result of the action of estrogen and 
progesterone (Craske, 2003; Craske & Chowdhury, 2005). The neurotransmitter 
serotonin may also play a role in responsiveness to stress and anxiety. Some evidence 
suggests that the female brain does not process serotonin as quickly as the male brain 
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(Craske, 2003; Craske & Chowdhury, 2005). Recent research has found that women are 
more sensitive to low levels of corticotropin-releasing factor (CRF), a hormone that 
organizes stress responses in mammals, making them twice as vulnerable as men to 
stress-related disorders. Additional explanations that attempt to account for these gender 
differences have included the differences in parenting styles and gender roles, the 
tendency for females toward greater negative affectivity, and the interaction of 
physiology and behavior on the development of anxiety disorders (Craske, 2003). 
Another possible explanation, as previously stated above, is the fact that male children 
are typically reinforced to be assertive and independent while female children are 
encouraged to be cautious and less independent (Craske, 2003).   
Women are more vulnerable to anxiety because of their tendency toward greater 
negative affectivity (Craske, 2003). Negative affectivity “is a broad and pervasive 
predisposition to experience negative emotions that has further influences on cognition, 
self-concept, and worldview” (Watson & Clark, 1984). It is also related to general life 
satisfaction. Those with high negative affectivity tend to experience states of anxiety, 
nervousness, guilt, and fear. Women often experience increased levels of negative 
affectivity as they get older, while males’ levels are likely to remain constant and tend to 
have lower levels overall (Craske, 2003). Negative affectivity can often interfere with 
one’s ability to effectively cope and thus leads to increased levels of anxiety (Craske, 
2003). 
 Additionally, research studies conducted on anxiety and its relationship to 
physiology and behavior demonstrate that there are some differences between male and 
female responses to stress (Craske, 2003). As discussed earlier, one benefit of anxiety is 
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the fight-or-flight stress response. This response essentially prepares the body to either 
fight the perceived threat or flee from it. It should also be noted that the response can be 
triggered by both real and imaginary threats. Changes occurring in the body during this 
time include an increased heart rate, muscles becoming tense, perspiring, and eyes 
narrowing, and hearing may become more acute (Craske, 2003). Some research studies 
have found that in females, there is a dampening effect of the fight or flight response, 
which is theorized to be caused by oxytocin and endogenous opiates (Craske, 2003). Put 
more simply in behavioral terms, this dampening effect results in women showing a 
blunted response to the fight-or-flight reaction. 
 
ANXIETY DISORDERS IN AFRICAN AMERICANS 
According to the 2013 U.S. Census Data report, African Americans make up 
roughly 13.1% of the U.S. population. Almost 25%, or 7.5 million, of African Americans 
have been diagnosed with a mental illness (Ward, Clark, & Heidrich, 2009). African 
American women might be overrepresented in this population because they are at a 
higher risk for developing mental illness. This is often due to factors that include lower 
income, poor health, multiple-role strain, and the “double minority status” of both race 
and gender (Ward, Clark, & Heidrich, 2009; Neal-Barnett & Crowther, 2000). The term 
double minority status is defined as “the psychological state created when two devalued 
identities interact to influence the individual in a way that is greater than the sum of the 
independent effects of those identities” (Gonzales, Blanton, & Williams, 2002). An 
individual belonging to multiple disadvantaged groups may encounter a “double 
disadvantage” when he or she is compared to both privileged and singly disadvantaged 
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people. Adults who are members of more than one of the disadvantaged groups were 
more like to report experiencing everyday and lifetime major discrimination and view 
these experiences as stressful. They were also more likely to report poor health than 
singly disadvantaged or privileged adults (Gonzales, Blanton, & Williams, 2002). 
The estimated lifetime prevalence of generalized anxiety disorder in African 
Americans is 5%. This is more than likely an underestimate. The National Alliance for 
Mental Illness (NAMI) estimates that only 1 in 3 African Americans will seek treatment 
for their mental illness. African Americans with co-occurring substance use and mental 
disorders are even less likely to use any professional services (Woodward et al., 2008). 
Most will tend to treat the physiological symptoms manifested from anxiety with their 
primary care physician (Ward, Clark, & Heidrich, 2009; Neal-Barnett & Crowther, 2000; 
Williams, Domanico, Marques, Leblanc, & Turkheimer, 2013). Shame or reluctance to 
be labeled mentally ill or experiences with racism often make it hard for African 
Americans to trust medical providers or institutions (Ward, Clark, & Heidrich, 2009; 
Neal-Barnett & Crowther, 2000; Williams, Domanico, Marques, Leblanc, & Turkheimer, 
2013). With that being said, many African Americans may be less likely to report 
excessive worried thoughts and instead focus on the manifestation of the physical 
symptoms associated with the disorder such as a racing heart, nausea, sleeplessness, and 
others. In addition, researchers and clinical staff may miss diagnosing GAD because they 
may not be asking questions about the specific things African Americans are likely to 
worry about, such as racism (Ward, Clark, & Heidrich, 2009). Although African 
Americans have lower rates of anxiety disorders than Caucasians, their anxiety disorders 
are more likely to persist (Breslau, Kendler, Maxwell, Gaxiola-Aguilar, & Kessler, 
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2005). This may be attributable to the fact that African Americans tend to seek medical 
health instead of mental health treatment and may also complain about somatic rather 
than emotional symptoms (Gonzales, Blanton, & Williams, 2002).  
The term “hard to reach” has emerged throughout health care and social service 
research in a context of the targeting of services to specific groups (Cortis, 2012). Simply 
put, it means that a hard-to-reach population is one that is difficult for researchers to 
access (Cortis, 2012). According to Faugier & Sargeant (1997), a hard to reach 
population is 
adults, young people and children from any ethnic background, regardless of  Do 
you want to put quotes here?migration status. They are “hard-to-reach” if their 
social circumstances, language, culture or lifestyle (or those of their parents or 
caregivers) make it difficult to access diagnostic and treatment services; self-
administer treatment; or attend regular appointments for clinical follow-up. 
The terms “hidden population” and “hard-to-reach population” are often used 
interchangeably but mean very different things. A hidden population is a population with 
no defined limits, such that its exact size cannot be known. Hidden populations often 
prompt research into sensitive subjects. Intravenous steroid users, for example, are a 
hidden population whose members could be damaged by disclosure of the phenomenon. 
People in underserved communities such as African Americans might be harder to reach 
because of a variety of personal or sociodemographic characteristics. Many cultural 
groups are reluctant to volunteer personal information because of the risk of social, 
political, or other discriminatory repercussions (Sadler, Lee, Lim, & Fullerton, 2010).  
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There are several potential reasons why African Americans do not seek treatment 
for mental illness. A few of the common barriers include the cultural components 
involved with mental health treatment. Shame or reluctance to be labeled mentally ill or 
experiences with racism often make it hard for African Americans to trust medical 
providers or institutions. Belief systems that are linked to cultural norms about 
engagement in healthcare services or a history of prior abuses of minority groups during 
the research process (such as the Tuskegee Experiments) also could potentially interfere 
with research participation (Elmir, Schmied, Jackson, & Wilkes, 2011).  
African Americans tend to seek comfort in other areas of their life, which includes 
clergy, colleagues, family, and members of their social network. In addition, there are 
often negative feelings toward mental health treatment, such as embarrassment and 
stigma in general, but especially in the African American community. There is the 
persistent notion of the idea of the “Strong Black Woman.” This culture is taught to 
endure hardships in silence and not seek out treatment outside of their family network. 
Also, many do not want to seem “crazy” to their peers. Another barrier could simply be 
not being able to afford treatment. One final barrier that often still plays a large part in the 
African American community outlook is the idea of institutional mistrust. Many still 
remember the horrific Tuskegee Experiments conducted in this county as recently as the 
1970s. 
Several common themes persisted throughout this review of literature on African 
Americans and mental illness treatment. These themes included the lack of available 
information on this topic, self and group perceptions of mental health issues, treatment-
seeking barriers, and finally, the low rates of African Americans in treatment studies and 
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clinical settings for anxiety. Williams, Domanico, Marques, Leblanc, & Turkheimer 
(2013) and Neal-Barnett & Crowther (2000) both outlined the common theme of the lack 
of relevant literature surrounding African Americans and anxiety disorders. African 
Americans’ distrust of physicians and the health care system in general may also 
contribute to this lack of relevant literature. Historically, African Americans, other 
minority groups, and women have all been underrepresented in clinical trials (Harris et al, 
2000). For African Americans, this could simply be attributable to a general lack of 
access to health care.  
African Americans’ negative race-related experiences have been associated with 
outcomes such as increased anxiety, depression, somatization, and substance use (Greer, 
2011). The strong historical background of African Americans as research subjects, 
which dates back as far as the Civil War, can illustrate how their attitudes and fears 
manifest. For example, the Tuskegee Syphilis Study, initiated in the 1930s, used African 
American sharecroppers in the South (Greer, 2011). Penicillin was not in use as a 
standard treatment for syphilis when the study was initiated. However, it became widely 
available in the 1940s and later became the standard treatment protocol for syphilis. The 
participants in the program were not made aware of this nor given the treatment until a 
public outcry in the 1970s (Greer, 2011). The effect of this study and other events may 
have led to current mistrust of treatment settings by this population. Even though there 
are several modern-day safeguards in place to prevent this type of abuse from happening 
again, the effects of this study and similar studies have not gone away.  
Another important facet of this issue outlined by Ward, Clark, and Heidrich 
(2009) is the fact that little research has been conducted to help determine how individual 
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beliefs and attitudes influence coping behaviors and treatment-seeking specific to African 
American women. Among African American populations, culture-specific efforts usually 
involve the use of spirituality and religion, support from friends and family, and the 
reliance on community and spiritual leaders to address perceived problems (Ward, Clark, 
& Heidrich, 2009) 
Basically, the issue regarding the lack of African Americans in mental health 
treatment may not be addressed because this population has found other ways to cope 
with their anxiety through such things such as prayer, meditation, or even substance use 
and abuse. 
More is needed in terms of specific cultural research on African American women 
and generalized anxiety disorder. In addition, since the majority of studies have been 
conducted on Caucasian women, it is hard to say whether the current treatment models 
can be generalizable to different races (Williams, Domanico, Marques, Leblanc, & 
Turkheimer, 2012). The lack of diversity of the participants that can be gathered for 
health promotion and intervention activities or research studies will limit the 
generalizability of the findings. This has a large impact on the clinical and treatment 
population. Since African Americans have different cultural beliefs when it comes to 
mental health services, this definitely must be taken into account in the future. The best 
mental health treatment approaches would have multiple components that are deemed 
culturally relevant and take into account the cultural identity shared by many African 
American women.  
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SUBSTANCE ABUSE 
Substance abuse is defined as the overuse, misuse, or addiction to any chemical 
substance such as tobacco, alcohol, or drugs, including over-the-counter, prescription 
medications, and illicit drugs (APA, 2000). Almost 23 million Americans older than age 
11 are diagnosed with substance abuse or dependence (SAMHSA, 2009). Substance 
abuse is one of the greatest causes of preventable death in the United States in the form of 
tobacco use. Adolescents and adults presenting for substance use disorder treatment often 
have co-occurring mental health disorders (Chan, Dennis, & Funk, 2008), which can 
further complicate diagnoses, assessment, treatment, and relapse prevention efforts 
(APA, 2000). As a result, substance use disorders contribute to significant social, 
financial, and disease burdens to those effected (Khalsa, Treisman, McCance-Katz, & 
Tedaldi, 2008).  
Individuals take drugs for a variety of reasons. The most often-stated reason is 
that drugs are fun and they make you feel good. Television has always shown alcohol and 
drug use under the guise of recreational fun. Also, drugs can act as a stress reliever. 
Taking drugs will allow you to forget or tune out your problems while you are under the 
influence. Young people and adolescents often take drugs to fit in or to not be seen as a 
social outcast. Others take drugs because they are simply bored or to rebel against their 
parents or other authority figures. Finally, many individuals state that they experimented 
with drug use for the first time because they were simply curious about the drug 
(McNeece & DiNitto, 2012). Given the various reasons that people take drugs, it is 
important to determine what will make some of these people become addicted while 
others may never become addicted and are able quit their drug use without further 
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intervention. Understanding these reasons will have strong implications for treatment 
effectiveness and the type of help given to a drug-addicted individual. 
The majority of people in most cultures will have at least some experience with 
substances (whether alcohol or other drugs) that can potentially develop into a 
problematic use pattern. However, most individuals who experiment with drugs will not 
become addicted. For example, many people throughout the world drink alcohol, but only 
a certain few will go on to become alcoholics. Environmental factors play an enormously 
powerful role in the development of an addicted individual in addition to their own 
genetic makeup (McNeece & DiNitto, 2012). 
The biological or genetic theory is currently the most widely held view of 
addiction etiology in the scientific community and the addition community as a whole. 
To discuss the biological theory, we must first briefly explain the processes of what 
happens in the brain. The brain is made up of the limbic system, which is also known as 
the reward or pleasure center of our brain (McNeece & DiNitto, 2012). Whenever we do 
something that makes us happy or feel good, a chemical called dopamine is released into 
the brain. Alcohol and other drugs are not the only things that can cause dopamine to be 
released into our blood stream. Our brain releases these chemicals in response to other 
things that we enjoy. However, when someone takes a drug, the amount of dopamine 
released into their bloodstream is far greater than many other activities (McNeece & 
DiNitto, 2012). This sudden surge of dopamine is what gives the user a sense of a “high.” 
Most drug addicts then spend the rest of their time trying to again achieve the same 
feeling with continued drug use. 
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The amount of dopamine released in response to drug use is substantially higher 
than in other everyday behaviors such as seeing a sunset or holding hands with a loved 
one (Drapela, 2006). Therefore, the brain will struggle to regain its normal chemical 
balance after the substance wears off. These negative and low feelings often lead a person 
to want to use drugs again to combat these low feelings. Over time, continued use of 
drugs can lead the brain to stop producing its own dopamine as it naturally does without 
the aid of a drug. This can lead to a physical dependency in which the drug-addicted 
individual needs to use more of the substance just to feel normal, creating a vicious cycle 
that can be difficult to break without further intervention (Drapela, 2006). 
Proponents of the disease or medical model of drug addiction speculate that 
because of this learning process that takes places within the brain, an eventual physical 
dependence on that substance will occur (McNeece & DiNitto, 2012). The individual has 
now become addicted to that drug. Their body needs that drug to feel normal. Under the 
disease model of addiction, the brain’s reward center becomes reorganized. The 
individual’s priorities are rearranged so that finding and using the substance (or another 
substance that will produce similar effects) becomes top priority as far as their brain is 
concerned. In this instance the drug has taken over all of the brain’s thought processes, 
and the addict is no longer in control of his or her own actions. An example used to 
illustrate this point noted by Buchman, Skinner, and Illes (2010) is that an alcoholic will 
not have trouble deciding whether to get in his car and drive to the store to get more 
alcohol because this urge to do so will be irresistible. The decision was already make for 
him when he became addicted to alcohol. 
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Many physicians, even the current director of the National Institute on Drug 
Abuse (NIDA), Nora D. Volkow, MD, believes that drug addiction is not a lifestyle 
choice but instead an abnormality of brain functioning. Many physicians feel that drug 
addiction should be placed in the same category as other serious psychiatric disorders that 
have a basis in the brain. This only reiterates the fact that there exists some type of 
interaction of genetic, psychological, and neurobiological predispositions to drug 
addiction. However, it is still important to explore whether other factors such as 
environmental influences can exacerbate this vulnerability (Feske et al., 2008).   
The accumulating knowledge regarding vulnerability to drug use and substance 
use disorders needs to be more thoroughly explored. There are several models that exist 
that claim to explain the origins of substance abuse. More interdisciplinary research that 
involves geneticists, neuroscientists, social and behavioral scientists, and social workers 
have helped to improve our understanding of drug use and substance misuse; however, 
more work is still needed. Individuals may be predisposed to drug use and drug use 
disorders; however, their actual engagement in these behaviors largely depends on their 
own environmental experiences (McNeece & DiNitto, 2012). This could have great 
implications for addiction treatment research as well as prevention strategies. The best 
addiction-treatment approaches should have multiple components and should help to 
better several affected areas of the addict’s life and not just look at achieving abstinence 
from drugs. 
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SUBSTANCE ABUSE AND MISUSE IN WOMEN 
Not surprisingly, evidence has accumulated to demonstrate gender differences in 
the occurrence and course of drug use disorders (McNeece & DiNitto, 2012). Among 
these differences is a more rapid progression among women than men from drug use to 
addiction and oftentimes greater impairment than males from drug use (McNeece & 
DiNitto, 2012). Female drug users tend to experience greater impairment concerning their 
health (e.g., complications during pregnancy, violence, and greater vulnerability to 
HIV/AIDS infection) and greater social consequences (e.g., criminal justice involvement, 
sex differences in motivation for and initiation into drug use, and in the biological effect 
of certain drugs also have been reported) (Brecht, O’Brien, Von Mayrhauser, & Anglin, 
2004).  
It is well known that substance abuse problems are more common in men 
compared to women; however, substance abuse problems are still considered a significant 
public health concern in women (McNeece & DiNitto, 2012;). There are currently 9 
million women who have used illegal drugs in the past year (McNeece & DiNitto, 2012), 
and 3.7 million women have taken prescription drugs nonmedically during the past year. 
More than 28,000 (70%) of the AIDS cases among women are drug-related. Research 
also demonstrates that women who drink face more health and social problems than men 
who drink (McNeece & DiNitto, 2012). 
The characteristics of women substance abusers are quite different than what is 
typically seen in males. Women usually tend to initiate substance abuse later. Usually 
they are influenced by men in their lives, such as a spouse or boyfriend, to start substance 
abuse (McNeece & DiNitto, 2012). Women also are more likely to suffer from a 
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comorbid psychiatric problem such as depression, anxiety, or a mood disorder and 
usually seek treatment earlier in the course of their addiction (Brady & Randall, 1999). 
Finally, problems related to substance abuse interfere with functioning in more areas of 
the lives of women as compared to their male counterparts (Fillmore et al., 1997). This is 
also an important issue because substance abuse is harmful during pregnancy as the 
growing fetus is adversely affected as well (Brady & Randall, 1999). 
Women involved in the criminal justice system have even higher rates of 
substance use compared to those with no involvement (Brady & Randall, 1999). Drug-
related offenses are one of the most common reasons women are incarcerated. According 
to the Bureau of Justice Statistics, “approximately 59.3% of state and 47.6% of Federal 
female prisoners surveyed in 2004 indicated that they had used drugs in the month prior 
to their offense” (Brady & Randall, 1999). Additionally, it was found that almost 60.2% 
of state and 42.8% of federal female prisoners surveyed in 2004 met drug dependence or 
abuse criteria (Brady & Randall, 1999). Understanding women’s addictions to substances 
is essential to address the health care needs of women, especially women incarcerated for 
illegal drug use. 
Women potentially face several barriers when they try to access substance abuse 
treatment. Women are more likely to seek care in mental health or primary care settings 
rather than in specialized substance treatment programs, which elicits poorer outcomes in 
regards to their substance use (Green, 2006). Women are more likely than men to 
experience economic barriers to treatment and other barriers that prevent them from 
seeking or following through with treatment (Brady & Ashley, 2005). These barriers 
include the need for adequate childcare, transportation to appointments, and income. As a 
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result of being in substance abuse treatment, women are more likely to report feeling 
shame or embarrassment than males (Thom, 1987). It is important to address these 
barriers so that more women will attempt to access treatment. When the barriers of 
housing, transportation, education, and income were addressed, it was found that women 
were less likely to use after treatment ended (Green, 2006). Addressing these barriers to 
treatment seems to protect against potential relapse.  
 
SUBSTANCE ABUSE AND MISUSE IN AFRICAN AMERICANS 
Current research on variations in risk for drug use disorders associated with sex, 
ethnicity, and age is minimal. Research on the link between mental and drug use 
disorders often has failed to incorporate individuals of varying sexes, ethnicities, and 
ages, effectively limiting the generalizability of their findings. Ethnic and racial 
minorities experience a variety of adversities including higher poverty rates and 
decreased opportunities for employment, education, housing, and medical treatment 
(SAMHSA, 2009; U.S. Census Bureau, 1999), which have been hypothesized to increase 
risk for mental and drug use disorders. Despite these adversities, African Americans have 
been found to have a lower prevalence and later onset of substance use. Once drug use 
has begun, studies have been inconsistent on the course of drug use among African 
Americans (SAMHSA, 2009). 
According to the 2012 National Survey on Drug Use and Health, an estimated 23 
million Americans age 12 and older use illegal drugs. The survey also reported that an 
estimated 22.2 million (age 12 or older) were classified with substance dependence or 
abuse in the past year. It has generally been shown that compared to their European 
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American counterparts, African Americans report a later initiation of alcohol during 
adolescence and generally lower rates and levels of use across adulthood. However, 
despite these findings, African Americans often experience more negative social 
consequences from drinking, experience more alcohol-related illnesses and injuries, and 
to some extent are more likely to report alcohol dependence symptoms or diagnosis 
(Barlow, 2001). Similarly, studies of racial and ethnic differences have found that 
Caucasians have higher prevalence rates of substance abuse disorders than other racial 
and ethnic groups, but the racial and ethnic minorities have been shown to have substance 
abuse disorders that persist for longer periods of time.  
Rates for substance abuse treatment admissions for African Americans have 
steadily declined 15% between 1994 and 1999, while rates for admissions for the total 
population have increased 3% (SAMHSA, 1999). Issues of race and gender that impact 
the target population may further impact treatment access and utilization. The outcomes 
of substance use disorders tend to be more negative, long-term, and pervasive for African 
Americans as compared to outcomes of other racial and ethnic groups (SAMHSA, 1999). 
Despite the availability of treatment options, research pertaining to best practices for 
substance abuse treatment specifically for African Americans is very limited because 
many of the previous studies have been conducted on Caucasian males. In general, 
African Americans are slightly less likely to receive substance abuse treatment, and that 
treatment received may be of poor quality (Clark et al., 2013). 
Even though the lifetime and current prevalence rates of illegal drug use are lower 
for African Americans than Caucasians, African Americans are still overrepresented in 
the health and criminal justice systems. The 2000 National Survey on Drug Use and 
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Health also showed higher drug abuse rates for Whites than for racial or ethnic 
minorities, except in regards to the abuse of crack cocaine and heroin. African Americans 
are overrepresented among incarcerated drug abusers in the United States when 
compared to European Americans and have lower rates of recovery from drug addiction 
after treatment. There has been no comprehensive research to date to specifically explain 
either this overrepresentation or lower rates of recovery among African Americans. The 
necessity to address cultural as well as personal issues is shown to be intrinsic to 
successful recovery among African Americans. 
 
PSYCHIATRIC COMORBIDITY 
Psychiatric comorbidity is defined as the presence, either simultaneously or in 
succession, of two or more specific disorders in an individual within a specified period 
(Wittchen, Perkonigg, & Reed, 1996). Comorbidity has major consequences. According 
to Graaf, Bijl, Smit, Vollebergh, and Spijker (2002), subjects with comorbid disorders 
often have higher service utilization rates than those with simply one disorder. 
Comorbidity has also been linked to more severe symptoms, greater functional disability, 
and longer illness course (Wittchen, Perkonigg, & Reed, 1996). In primary health care 
settings, comorbidity increases the chances that mental disorders will be recognized and 
increases the likelihood of receiving treatment. In the National Comorbidity Study, more 
than half (59%) of all 12-month disorders occurred in the 14% of the population with a 
history of three or more disorders (2000). These subjects were more likely to be female, 
15 to 24 years old, and residents of major metropolitan areas and to have lower income 
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and educational attainment levels compared with subjects without a history of three or 
more disorders.  
Anxiety disorders are typically comorbid with each other as well as with the 
depressive disorders (APA, 2000). According to Kushner, Sher, & Erickson (1999), 
substance use disorders and anxiety disorders are highly correlated. Substance use 
disorders may also occur with anxiety in adults, with both substance use and anxiety 
serving as risk factors for each other. The presence of an anxiety or substance use 
disorder is also a risk factor for the presence of the other disorder, as shown in both 
epidemiological and clinical samples. For example, one 7-year study demonstrated that 
the presence of an anxiety disorder quadrupled the risk for the onset of alcohol 
dependence (Kushner, Sher, & Erickson, 1999). It was also found that alcohol 
dependence increased the risk for an anxiety disorder by 3 to 5 times. Lastly, a couple of 
longitudinal studies conducted on samples outside of the U.S. have indicated that anxiety 
disorders may lead to substance use disorders (Goodwin, Ferguson, & Horwood, 2004). 
Typically, when the pattern of onset for mental and drug use disorders has been 
examined, the anxiety disorders have tended to precede drug use disorders (Lopez, 
Turner, & Saavedra, 2005). However, when examining the literature on the link between 
mental and drug use disorders, comorbid patterns are often described but comorbidity has 
not been fully been controlled for in the analyses (Chilcoat & Breslau, 1998a, 1998b). 
The diagnosis of current mood or anxiety disorders among active substance 
abusers is complicated by the fact that many symptoms of intoxication and withdrawal 
from alcohol and other substances often resemble the symptoms of mood and anxiety 
disorders (tremors, nausea, irritability). The association between most substance use 
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disorders and mood and anxiety disorders show a positive and significant correlation, 
which suggests that treatment for a comorbid mood or anxiety disorder should also be 
administered to those individuals with substance use disorders (Miller & Carroll, 2006). 
However, the nature of current co-occurrence of substance and mood or anxiety disorders 
remains largely unexamined and poorly understood. As previously stated, the relationship 
between co-occurring substance use and other psychiatric disorders may be particularly 
relevant for women, who have both higher overall rates of mood and anxiety disorders as 
well as higher rates of co-occurring substance use and psychiatric disorders relative to 
men (Kessler, Chiu, Demler, & Walters, 2005).  
Previous studies have shown that longer periods of abstinence (percent of days, 
whether consecutive or not) and longer durations of sustained abstinence (consecutive 
days only) yield benefits in a wide array of physical, psychological, and social 
functioning domains, including social network improvements, increased vocational 
involvement, and better mental health (Kessler, Chiu, Demler, & Walters, 2005). All of 
this information strongly indicates that becoming free from substance abuse will greatly 
increase one’s quality of life. 
Generalized anxiety disorder and substance abuse disorder commonly co-occur; 
however, there is little data for how to treat these types of cases (Kushner, Sher, & 
Beitman, 1990). It is estimated that 50 to 60% of women entering substance abuse 
treatment have a co-occurring mental disorder (Newmann & Sallmann, 2004). Another 
study that examined the link between mental and drug use disorders was Goodwin and 
colleagues (2002), who used a clinical sample comprising mostly females (66%) 
currently in treatment. This study controlled for demographic characteristics and 
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psychotic disorders, which included schizophrenia and schizoaffective disorder. They 
found that anxiety disorders increased the risk for drug use disorders, including cocaine, 
sedative, stimulant, and opioid disorders, among patients with affective (or mood) 
disorders. Results from this study also suggest that comorbid depression and anxiety 
disorders do not increase risk for drug use disorders among females receiving outpatient 
treatment. It is hard to determine whether these findings generalize to individuals of 
varied age and ethnicities. 
 
INTERSECTIONALITY 
Intersectionality, which is defined as the theory of how different types of 
discrimination interact (Crenshaw, 1989) gathered its roots from Black feminist thought. 
Crenshaw originally coined the term when discussing anti-discrimination law and argued 
that Black women were discriminated against in ways that often do not fit neatly within 
the legal categories of either “racism” or “sexism” but as a combination of both 
racism and sexism. This theory recognizes the fact that gender, race and class are 
interconnected as “intersecting oppressions” (Crenshaw, 1989). There are many health 
disparities that can be attributed to social inequalities; however, previous attempts to 
explain these inequalities tend to solely focus on a single demographic factor, such as 
sex, race, or socioeconomic status. This approach is inadequate in thoroughly explaining 
these disparities. 
It is important to look at all of these when studying African American women as 
their position falls within groups including that of disadvantaged gender, racial, and class 
statuses. The key aspect of intersectionality is the fact that multiple oppressions are not 
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each experienced separately but rather as a single, combined experience. Proponents of 
the intersectionality theory argue that the oppressions associated with each of these 
disadvantaged statuses are inextricably linked with each other and these issues are not 
currently discussed in research (Collins, 2000). 
  
TREATMENT FOR ANXIETY AND SUBSTANCE USE DISORDERS 
DSM-IV-TR criteria are used to make a diagnosis of GAD. Generalized anxiety 
disorder frequently co-occurs with physical illness or drug conditions; therefore, a 
complete medical examination is recommended. Treatment for GAD typically consists of 
psychological or pharmacological interventions. The psychological treatment for GAD 
usually takes the form of cognitive, behavioral, or supportive therapy (Starcevic, 2005). 
There are many appropriate mental health treatment programs for both anxiety 
disorders and substance abuse disorders but very few outlined to combat both disorders 
simultaneously. Clinicians must decide which disorder to treat first, whether it makes 
sense to treat one disorder in isolation from another, which treatment or treatment 
approach to use, and how to evaluate treatment progress (Kessler, Chiu, Demler, Walters, 
2005). There are several theoretical health framework models that can describe both 
generalized anxiety disorder and substance abuse separately.  
The high rate of comorbidity between drug use disorders and other mental 
illnesses calls for a comprehensive approach that identifies and evaluates both disorders 
(Kessler, Chiu, Demler, & Walters, 2005). It is important that once an anxiety disorder 
has been diagnosed, the specific type of disorder (social anxiety, generalized anxiety, 
etc.) or the combination of disorders that are present must be identified as well as any 
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coexisting conditions, such as depression or substance abuse. Additionally, anyone 
seeking help for either drug abuse or addiction or generalized anxiety disorder should be 
checked for both and treated accordingly since they commonly co-occur (Kessler, Chiu, 
Demler & Walters, 2005). Also, substance abuse can have such a strong effect on the 
individual that treating the anxiety disorder must often wait until the substance abuse or 
dependence conditions are first managed. It is also important to note that no single 
treatment will be deemed appropriate for everyone.   
Depending on the substances used, detoxification is often the first step in treating 
addition. Cognitive-behavioral therapy (CBT) has been shown to be very useful in 
treating individuals with anxiety disorders as well as substance abuse disorder. The 
cognitive part helps people change the thinking patterns that support their fears and 
anxieties, while the behavioral component helps people change the way that they react in 
anxiety-provoking situations. CBT has also been shown to reduce anxiety in cognitively 
intact older adults with generalized anxiety disorder (Padwa, Larkins, Crevecoeur-
Macphail, & Grella, 2013). Thus, beginning the CBT treatment would help with the 
reasons individuals use drugs and may also help the patient recognize anxiety-provoking 
situations and how to deal with them. The goal of CBT is basically to change thoughts 
and behaviors as related to anxiety and substance abuse. In addition to the CBT, most 
effective treatment programs use individual, family, and group counseling as a form of 
treatment.  
Behavioral therapies are the most commonly used forms of drug abuse treatment 
(SAMHSA, 1999). Behavioral therapies can vary but may involve addressing a patient’s 
motivation to change, providing incentives for abstinence, looking at the patient’s 
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reinforcers for staying abstinent, teaching drink and drug refusal skills, and trying to 
replace the time spent on drug-using activities with more constructive and rewarding 
activities. Behavioral techniques also involve improving the patient’s problem-solving 
skills and communication skills in hopes of facilitating better relationships with friends 
and family. Also, participation in group therapy and other peer-support programs during 
and following treatment can help maintain abstinence.  
Finally, it is also important to implement a systematic follow-up program for the 
clients after treatment has ended in order to determine instances of drug-free behavior 
and employment versus situations where relapse has occurred. Once the patient has dealt 
with their drug addiction, then strategies for maintaining their levels of anxieties can be 
addressed. 
Strategies for addressing generalized anxiety would include additional CBT 
training on managing anxiety-provoking situations and ways to decrease anxiety. 
Cognitive-behavioral therapy aims to recognize and change the patient’s thinking patterns 
associated with the anxiety and troublesome feelings. This type of therapy has two main 
parts: a cognitive part designed to limit distorted thinking and a behavioral part designed 
to change the way people react to the objects or situations that may trigger anxiety. CBT 
training specifically for anxiety often incorporates a variety of relaxation techniques or 
physical relaxation methods as well as meditation techniques (Wittchen, 2002). Many 
anxiety sufferers also benefit from group therapy sessions where they can discuss their 
feelings of anxiety with others having similar issues. Through group therapy, those with 
anxiety are taught to replace the negative thoughts or worries they have with coping self-
talk (Wittchen, 2002). They might be encouraged to make a list of the negative thoughts 
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they have and are invited to write a list of positive thoughts to replace them. Finally, 
medical treatments for anxiety utilize several types of drug classes. If the cause of the 
anxiety is a physical ailment, treatment will be designed to eliminate the particular 
ailment. Medications typically used to treat anxiety include antidepressants, 
benzodiazepines, tricyclics, and beta-blockers to control some of the physical and mental 
symptoms (Wittchen, 2002).  
It is also important to gauge the patient’s overall treatment satisfaction throughout 
treatment. This can be done with a short survey called the Treatment Satisfaction Index 
(TxSI), which gauges the client’s satisfaction with their therapist and with treatment 
overall. The index is usually done early on in treatment, after at least the second session 
has occurred, and again at the completion of the treatment program. 
Treatment should vary depending on the type of drug and the characteristics of 
the patients. Matching treatment settings, interventions, and services to an individual’s 
particular problems and needs is critical to their success in returning to productive 
functioning in the family, workplace, and society as a whole (Padwa, Larkins, 
Crevecoeur-Macphail, & Grella, 2013). 
Comorbid mental health problems such as depression or anxiety are common in 
individuals with alcohol and other drug problems. In studying the link between anxiety 
and substance use and abuse, potential moderating factors that have merited consideration 
based on past research include demographic variables of gender, age, and ethnicity. 
However, little is known about the occurrence of this association specifically in African 
American female substance abusers. The results of this literature review confirm and 
strengthen the findings that there is not a lot of research that specifically focuses on 
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African American women and their experiences with comorbid diagnoses of generalized 
anxiety disorder and substance abuse disorder. 
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CHAPTER 3 
RESEARCH METHODS 
 
RESEARCH DESIGN 
In compliance with the regulations of the University of Illinois Institutional 
Review Board (IRB), the permission for conducting the research must be obtained from 
the IRB (Institutional Review Board, 2014). The IRB Application for Review of 
Research Involving Human Subjects Form was filed, providing information about the 
principal investigator, the project title and type, source of funding, type of review 
requested, and number and type of subjects. Application for research permission 
contained the description of the project and its significance, methods and procedures, 
participants, and research status. It has been determined that this project as described 
does not meet the definition of human subjects research as defined in 45CFR46(d)(f) or at 
21CFR56.102(c)(e) and is considered exempt. 
This dissertation used secondary analysis of longitudinal study data previously 
collected. Secondary data analysis is theoretically the analysis of data collected by 
someone else (Boslaugh, 2007). This typically consists of the analysis of the data in order 
to answer a research question other than the original questions for which the data were 
initially collected. This is in contrast to primary data collection and analysis, in which the 
same individual or team of researchers designs, collects, and analyzes the data. A key 
strength of a longitudinal study is the ability to measure change in outcomes or exposure 
at the individual level (Rogosa, 1979). Longitudinal studies provide the opportunity to 
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observe individual patterns of change and also use those changes to analyze group data 
(Cook & Campbell, 1979). In repeat-measures designs the variability between subjects 
can be isolated, and analysis can focus more precisely on treatment effects (Cook & 
Campbell, 1979). Another important practical implication of a longitudinal study is that a 
one-time treatment assessment that assesses for a behavior at a single point cannot 
sufficiently link the correlation between two different variables. 
 
PARTICIPANTS 
Data are from the Pathways to Recovery study (e.g., Dennis, Foss, & Scott, 2007; 
Dennis, Scott, Funk, & Foss, 2005; Scott, Foss, & Dennis, 2005; Scott, Dennis, Laudet, 
Funk, & Simeone, 2011), a longitudinal study that began in 1996. As part of the original 
Chicago Target Cities study (Scott, Muck, & Foss, 2000; Scott, Foss, & Sherman, 2003a, 
2003b), a sample of 1,326 participants was recruited between 1996 and 1998 from 
sequential admissions (participation rate: 85%) of patients admitted to a network of 22 
addiction treatment programs operating on the west side of Chicago (10 outpatient drug-
free programs, five intensive outpatient drug-free programs, three methadone 
maintenance clinics, two short-term inpatient clinics, one long-term inpatient program, 
and one halfway house). Participants were re-interviewed at 6 months, 2 years, and 
annually thereafter for 9 years (follow-up rates per wave were 92% to 96%). In order to 
be eligible, participants had to a) reside in the city of Chicago or declare themselves 
homeless, b) report alcohol or drug use in the preceding 6 months (or the 6 months before 
being in a controlled environment), c) present for treatment at one of the publicly funded 
treatment programs in the study, and d) be 18 years of age or older. Individuals seeking 
treatment as a result of a DUI Level 2 or higher conviction were excluded because their 
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treatment-placement decisions were typically made outside the treatment system being 
studied (i.e., by a court officer). Informed and voluntary consent to participate was sought 
under the supervision of both the state’s and Chestnut Health Systems’ institutional 
review boards.  
High rates of attrition often challenge the validity of longitudinal studies. There 
are many reasons why individuals do not continue with longitudinal studies. These 
reasons include participant death, moving out of the area, refusing to participate, 
homelessness, and some adverse occurrence from a previous wave of research (Scott, 
Sonis, Creamer, & Dennis, 2006). Christy K Scott of Chestnut Health Systems has 
developed a method (2004) that seeks to attrition in longitudinal studies in the substance 
abuse field, based on a theoretical model of the ways that substance users are often lost to 
follow-up. This method has consistently yielded low attrition rates of less than 10% in 
her studies (Scott, Sonis, Creamer, & Dennis, 2006). She has been able to do this by 
specifically examining the reasons that drug users might be lost to follow-up as well as 
identifying opportunities for intervention in order to minimize that loss. The four 
dominant behavior patterns that she noticed among drug users that were thought to 
impact attrition were 1) mobility; 2) the cyclic pattern of addiction involving relapse, 
recovery and treatment; 3) social withdrawal, and 4) involvement with institutional 
settings (Scott, Sonis, Creamer, & Dennis, 2006). Scott has identified six areas of 
importance in terms of minimizing attrition in longitudinal studies. These areas include 1) 
delineation of staff roles and responsibilities; 2) engagement of institutions and 
organizations that interact with the research participants; 3) development and use of 
appropriate written materials for education, consent, and tracking participants over time 
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(“locator” forms); 4) development and implementation of the engagement, verification, 
maintenance, and confirmation (EVMC) protocol; 5) monitoring of staff compliance with 
the EVMC protocol; and 6) facilitation of regular case review meetings (Scott, Sonis, 
Creamer, & Dennis, 2006). This model has shown to be effective in producing 
longitudinal study follow-up rates over 90% with individuals who have substance use 
disorders. 
In terms of attrition, to adequately address the current study’s research questions 
(centering on multivariate relationships between baseline, Years 2–9, and Years 15 and 
16 variables) this study focused on only a subset of the sample to include participants for 
whom all data was available from baseline to Year 16. In order to get an accurate picture 
of substance users with generalized anxiety disorder, only participants available for all 
waves of data analyzed were included. If a participant was not available for Years 9, 15, 
and 16, then their information was not included in the study. The one downside to 
utilizing this method is the fact that there is the risk of bias because of incomplete follow-
up, or “drop-out” of study participants. If subjects who are followed to the planned end of 
study differ from subjects who discontinued follow-up, then the analysis may provide 
summaries that are not representative of the original target population as a whole. 
However, looking at the changes over time using all waves of data would allow for the 
opportunity to measure change more accurately by looking at more time points than just 
two and looking at a larger sample to make those inferences. 
The main study instrument was an augmented version of the Addiction Severity 
Index (ASI), which includes questions on age, lifetime and past-month problem severity, 
employment, family situation, and psychiatric functioning (Keller & Craske, 2008). This 
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instrument measures fear of physical signs of anxiety and has an internal consistency of 
0.84. to 0.90 (Keller & Craske, 2008). The instrument was modified to collect more 
detailed data on treatment and incarceration histories, service use, high-risk behaviors, 
mental distress, pregnancy, illegal activity, criminal justice involvement, recovery 
environment, drug use practices (or lack thereof) of friends, impact of substance use on 
relationships, type of disability or chronic condition, body mass index, motivation, and 
coping.  
The Scott method of participant retention as outlined above was used for this 
study. The participants were interviewed at 6 months, 18 months, 2 years, 3 years, 4 
years, 5 years, 6 years, 7 years, 8 years, 9 years, 15 years, and 16 years post-intake, with 
Year 17 and Year 18 currently scheduled to be completed. The follow-up protocol 
involved routine contact with each participant between interviews. If the participant could 
not be contacted, the researchers attempted to reach collaterals and service agencies with 
which the participant had dealings to reestablish contact. If they learned from these 
sources or public records that a client had died, they then recorded the period of death 
(i.e., at what point in the study the death occurred); however, they did not record the date 
of death or information on the cause of death (Garner, Scott, Dennis, & Funk, 2014). 
Participants received $50 for completing the interview, $10 for completing it on time, 
$15 for a urine sample, and $5 for confirming their appointment. Participants received 
$100 for completion of the Year 15 interview and $110 for completion of the Year 16 
interview. For both interviews, participants received an additional $10 if they completed 
their interview within 7 days of the targeted follow-up date. On average, each interview 
lasted 128 minutes.  
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In this analysis, data from over 750 women enrolled in the treatment study were 
examined to determine whether their symptoms of anxiety would improve with treatment 
for their substance abuse. Age, insurance, religion, homelessness, dependent children, 
dually diagnosed, criminal-justice charged, receiving public aid, age first used drugs, 
employment status, and education were included in the models as control variables. 
All African American female participants were included in the intake analysis, 
regardless of psychiatric diagnoses at baseline, in order to examine the range of their 
clinical symptoms and their progression over time. For all research questions the analysis 
was limited to the baseline assessment completed at the initial intake, assessments from 
Years 2–9, and the most recent years of data collected, Years 15 and 16. The many 
benefits to using this dataset are the fact that there is an oversampling of the intended 
research population (African American women), which allows for an increased statistical 
precision.  
 
VARIABLES IN THE QUANTITATIVE ANALYSIS 
A copy of the assessment administered can be found in Appendix I. Variables 
used in the assessment have been summarized in the table below. The requested dataset 
includes the following variable topics: 
 
Domain variables, scales, and subscales 
 
Background (demographics) Entire B section  
Substance Use (alcohol, marijuana, and 
other drugs) 
Entire S section  
Physical Health Entire P section 
Risk Behaviors and Disease Prevention R6 
Mental and Emotional Health Entire M section 
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Vocational (School, Work, Financial) V7, V7a 
SW. Satisfaction with Life Scale SW1, SW2, SW3, SW4, SW5 
EQ. Quality of Life EQ1, EQ2, EQ3, EQ4, EQ5, EQ6 
E. Environment and Living Situation E1 
SE. Stressful Events Entire SE section 
LS. Loneliness Scale Entire LS section 
PS. Perceived Social Support Scale Entire PS section 
PF. Perceived Family Support Scale Entire PF section 
RC. Recovery/Coping Supplement Entire RC section 
 
DATA ANALYSIS 
The statistical software program Stata was used for in-depth data analyses. To 
begin the data analysis process, descriptive statistics were calculated on the variables to 
summarize and describe the data collected. The approach to data analysis involved two 
levels of examination: 1) bivariate analysis for descriptive purposes (depending on the 
variable type), correlations, and survival analysis to document the association between 
the independent variables and outcome variables, and 2) multivariate regression analysis 
for correlation between all waves of data analyzed.  
A survival analysis and a Cox regression analysis were used to analyze the data 
from the Pathways to Recovery study (e.g., Dennis, Foss, & Scott, 2007; Dennis, Scott, 
Funk, & Foss, 2005; Scott, Foss, & Dennis, 2005; Scott, Dennis, Laudet, Funk, & 
Simeone, 2011). Survival analysis (also known as failure-time analysis or event-time 
analysis) is defined as a set of methods for analyzing data where the outcome variable is 
the time until the occurrence of a specific event of interest (Cox & Oakes 1984; Hosmer, 
Lemeshow, & May, 2008). The event can be death, occurrence of a disease or illness, 
marriage, divorce, or even the time it takes to complete a doctoral dissertation. The time 
until the event occurs, or survival time, can be measured in any unit such as days, weeks, 
or years (Cox & Oakes, 1984). Using a medical example, if the event one is interested in 
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studying is a stroke, then the survival time would be the time in years until a person has a 
stroke (Hosmer, Lemeshow, & May, 2008). The survival-time model would need to 
include the origin date, a time scale, and the definition of the event (Cox & Oakes, 1984). 
In terms of the Pathways study data that involved examining the occurrence of GAD in 
the sample, the origin would be the beginning of the study (1996), with the time scale 
being measured in years. The definition of the event would be the time until the person 
develops GAD as diagnosed through the assessment. The event of developing GAD is 
determined and diagnosed using questions embedded throughout the assessment. It is 
important to note that in order to calculate a survival analysis, one must exclude 
participants who had already had been diagnosed with GAD at baseline, thus reducing the 
overall sample size. An important feature of survival data is the possibility of right-
censoring. This would occur if the event of GAD never happened or if GAD diagnoses 
occurred outside of the measured window (Year 16). When the study data ends at Year 
16, there may still be some individuals who never had the event occur, or the event could 
potentially occur after Year 16, but this information would not be captured.  
The dependent variable in survival analysis comprises two different items. The 
first is the time until the event occurs and the second is the event status, which records 
whether the event of interest has occurred (Cox & Oakes, 1984). A survival analysis 
would be beneficial to calculate in terms of the Pathways dataset because there are also 
many other covariates available to help explain the distribution. 
 The one downside to looking at the data in this manner is that it will not provide 
detailed information on the possible interaction of GAD and SUD because it looks only at 
one specific event, and that is the event of developing GAD. Additionally, since 
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individuals who present with GAD at baseline have to be excluded, the sample size will 
be greatly reduced. A smaller sample size will decrease the external validity of the 
findings and the generalizability of the study and increase the probability of a Type I 
error (Cook & Campbell, 1979). 
The second method that was used to analyze the data, in addition to the survival 
analysis, was an individual mixed-effects logistic regression. The Cox regression analysis 
was one model used to analyze this dataset. A Cox proportional-hazards model estimates 
both the probability that an event will occur and the probable time to failure (Cox & 
Oakes, 1984). Cox regression aims to estimate the hazard ratio. The Cox model allows 
for an easy method to incorporate time-dependent covariates, or variables that may 
change in value over the course of the observation period (Cox & Oakes, 1984). This 
type of model can account for the correlation of observations and allow estimation of the 
effect of predictor variables on repeated outcomes (Blood, Cabral, Heeren, & Cheng, 
2010). This model would be appropriate since the dependent variable is dichotomous 
(does the individual have GAD or not?). Also, this type of model is robust to missing 
data, which is beneficial because Years 10–14 were not collected after funding ran out 
during this period. A mixed-effects model focuses on the introduction of random effects, 
which are the items of the model that can vary across individuals (education and coping 
strategies), while the fixed effects are the relationships that are assumed identical for 
every subject (Blood, Cabral, Heeren, & Cheng, 2010). In the current study the fixed 
effects would be race and gender, since those remain the same for all the participants 
throughout each collection wave. Using a mixed-effects approach will attempt to 
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indirectly describe and interpret the covariance structure for the longitudinal 
observations. 
Education might be a moderating variable in that the relationship between GAD 
and substance abuse or dependence could be stronger for those with more education and 
less strong or nonexistent for those with less education. Moderation helps one to 
understand how an individual variable can strengthen or change the direction of the 
relationship between the independent variable and dependent variable (Baron and Kenny, 
1986). Also stated in terms of this study, the level of education achieved might change 
the relationship between GAD and SUD. We would determine this if the third variable of 
education was shown to modify the relationship of anxiety (X) and substance abuse or 
dependence (Y) such that the X to Y relationship differs at different values of the 
education variable (measured by highest level of education completed). This would 
indicate that the education variable is a moderator. The only assumption necessary of 
moderation is the fact that the relationship between the independent variable and 
dependent variable is different at different levels of the moderating variable (Baron & 
Kenny, 1986). It is possible to access moderating effects indirectly through subgroup 
analysis (Baron & Kenny, 1986). If the moderator is level of education, then using a 
subgroup approach, multiple regressions would be run while using each of the categories 
for education. Similarly, coping skills could be shown to modify the relationship between 
anxiety (X) and substance abuse or dependence (Y) such that the X to Y relationship 
differs at different values of the types of coping skills utilized (high, moderate, or low).   
All waves of the data available were used in the analysis. This includes baseline 
through Year 9 and Years 15 and 16. In order to see change over time it was important to 
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look at more than two points in the dataset. At each time point, observations of several 
variables were obtained. It is also important to note that the study was completed 
annually from baseline to Year 9, and then there was a break until Year 15 because of the 
lapse in funding. Limiting the analysis to intake and the last wave of data would not tell 
as complete a story in comparison to looking at all waves of data.  
Ideally, a true experiment is used to establish cause and effect by manipulating an 
independent variable, the treatment or experimental variable, in order to see its effect on a 
dependent variable, or the criterion or outcome variable. This could be accomplished by 
randomly drawing participants from a population, measuring baseline covariates, or 
assigning and measuring treatments using a control group that received no treatment, then 
analyzing the outcomes. Given the nature of this study, that approach would not be 
feasible or ethical to conduct. These participants were assessed for generalized anxiety 
disorder and substance abuse or dependence (will be abbreviated as SUD for simplicity) 
criteria upon intake, but they were originally treated for problems related to their 
substance abuse, since it was the reason behind their intake at the 22 different addiction 
programs. Thus, from the Pathways dataset there is no way to determine whether the 
women were first suffering from generalized anxiety disorder or a substance use disorder. 
Both outcomes are possible and unable to be determined given the data’s current form. At 
the initial assessment as well as on subsequent follow-up assessments the women were 
asked about symptoms as they related to both disorders only in terms of the preceding 12 
months. Diagnoses for generalized anxiety disorder and substance use disorder can be 
made from the initial assessment as well as from follow-up assessment waves. The intake 
data also included severity ratings for primary, secondary, and tertiary substances rated as 
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either 1) no abuse or no dependence, 2) abuse, and 3) mild, moderate, or severe 
dependence. A causal effect of anxiety on substance use disorder is also limited by the 
lack of randomization of the research participants, since randomized experiments are 
considered the core design for causal inference.  
The Pathways assessment is made up of several biopsychosocial constructs, 
including detailed data on treatment and incarceration histories, service utilization, high-
risk behaviors, mental distress, pregnancy, illegal activity, criminal justice involvement, 
recovery environment, drug use practices (or lack thereof) of friends, impact of substance 
use on relationships, type of disability or chronic condition, body mass index, motivation, 
and coping (Scott, Dennis, Laudet, Funk, & Simeone, 2011). Therefore, since multiple 
variables were measured over time, the relationship of these variables should help in 
understanding the sequence of events in regards to generalized anxiety disorder and 
substance abuse.  
It would be worthwhile to determine what made someone with generalized 
anxiety disorder in this group successful in their substance abuse treatment versus 
someone who was not successful in overcoming drug addiction. This would be possible 
because of the simple fact that since this sample spans 15 years, 36% are reporting to be 
in recovery. Looking at past-year abuse or dependence for African American women at 
Year 15, 25% report any disorder (abuse or dependence), 5% for alcohol, 13% for 
cocaine, 12% for opiates, and < 1% for marijuana. So there is a good portion of the 
sample in recovery to compare to those who are still active in drug use.  
There are many other variables collected in the study that could help determine 
potential reasons some women were successful and others were not. First, there is a 
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supplemental section called Coping Strategies, which lists potential strategies in addition 
to drug treatment that these women have utilized. It would be important to see whether 
those who are reporting to be in recovery used several of the same coping strategies, such 
as friend or family supports, church supports, meditation, or prescription medication, 
among others. This would have potential implications for future interventions with this 
population. For example, if the majority of women currently abstinent from alcohol and 
other drugs also utilized church supports, then it would make sense to incorporate such 
strategies into future treatment plans for this population.  
Using the Pathways dataset to answer the current research questions consists of 
completing a nonexperimental design or passive-observational design (Cook & 
Campbell, 1979). This is a nonexperimental design because there is no manipulation of 
the independent variable (Cook & Campbell, 1979). The independent variables in the 
current study are generalized anxiety disorder and anxiety and fear symptoms from the 
Anxiety Fear Symptom Scale (AFSS).  
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The conceptual framework for the current study is included below: 
 
Conceptual Framework 
 
 Independent Variable Dependent Variables 
 
 
 
 
 
 
 
                                                                                                                         
 
  
                
 
 
Moderating Variables 
 
Substance Use Disorder 
(SUD): 
 
ASI Alcohol Composite 
Score 
 
ASI Drug Composite Score 
 
Generalized Anxiety 
Disorder (GAD) 
Acquired (Y/N) 
 
Severity of Anxiety/Fear 
Symptoms 
 
 
Education 
 
 
Coping Skills 
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CHAPTER 4 
RESULTS 
 
 
DESCRIPTION OF SAMPLE 
In this chapter the results of the survival analyses and Cox regression analyses 
will be described. Characteristics of the sample are described at the beginning. The 
control variables were measured at intake only. Symptoms of anxiety from the AFSS 
were not measured until Year 6 and from there until the end of the study (Years 6–9 and 
Years 15 and 16). Therefore, it was not possible to use information from all waves when 
predicting GAD and anxiety-fear severity symptoms. Data from Years 6–9 and Years 15 
and 16 will be used when predicting anxiety-fear symptoms, while data from Years 0 
(intake), 6–9, and 15–16 will be used when predicting GAD.   
First, demographics were examined and statistical tests were run to analyze the 
quantitative data (see Table 1). The individual characteristics at intake included a total N 
= 697. At intake, participants ranged in age from 19 through 56 years old (M = 33.62; SD 
= 6.62). The sample was 100% African American and female as reported at intake. 
Participants were asked about the highest level of education completed: 36.7% reported 
having a high school diploma with an additional 4.7% reporting having a GED and 5.2% 
reported having an associate’s degree or higher. The majority of the sample, 53.4% (n = 
372), reported no degree at all. 
A full 32.7% (n = 228) of the sample reported being homeless at intake with 
71.5% (n = 484) also reporting having dependent children. The majority of the sample 
was receiving public aid at intake (64.6%; n = 450). For employment, 73% of participants 
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described their current employment status as not employed, 14.4% reported full-time 
employment, 8.3% reported part-time employment, and 4.3% reported “else,” which 
includes being in a controlled environment such as treatment or incarcerated. In terms of 
health insurance, the majority of respondents 53.1% (n = 357) reported being uninsured, 
33.43% (n = 225) were on Medicaid, and 13.52% (n = 91) had some type of private 
insurance. For religion, 89% of the sample reported having some type of religious 
affiliation, with the majority of those (75.4%, n = 524) indicating that they were 
Protestant. 
Only 12.9% (n = 80) of the sample was dually diagnosed as of the intake 
assessment. Over half of the sample (54.4%, n = 357) had some criminal justice charges 
in their lifetime.   
The participants were also asked the age of their first drug use at intake: 10.1% of 
respondents reported being 12 or younger when they first used drugs, 52% reported being 
13–17 years, 26.3% were 18–24 years, and 11.7% were 25 years or older. Finally, the 
dependent variable GAD was measured at intake only, and then starting from Years 6–9 
and Years 15 and 16. Over a third, or 37.2% (n = 258), presented with generalized 
anxiety disorder at intake, which is right in line with current estimates of those suffering 
from both anxiety disorders and substance use disorders. 
 
Table 1. Individual characteristics at intake 
    
Variable N Percentage Mean/ 
Standard deviation 
    
Age (mean) 697  M = 33.62  
SD = 6.62 
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Table 1 (cont.) 
 
Insurance 
Uninsured 357 53.05  
Medicaid 04 225 33.43  
Else 91 13.52  
    
Religion    
None 75 10.79  
Protestant  524 75.40  
All else 96 13.81  
    
Homeless    
No 469 67.29  
Yes  228 32.71  
    
Dependent children    
No 193 28.51  
Yes  484 71.49  
    
Dually diagnosed    
No 542 87.14  
Yes  80 12.86  
    
Criminal justice charged    
No  299 45.58  
Yes            357 54.42  
    
Receiving public aid    
No 247 35.44  
Yes 450 64.56  
    
Age first used drugs    
≤ 12 70 10.07  
13–17  361 51.94  
18–24 183 26.33  
≥ 25 81 11.65  
    
Employment status    
Not employed 508 72.99  
Full-time 100 14.37  
Part-time 58 8.33  
Else  30 4.31  
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Table 1 (cont.) 
 
Highest degree received 
None 372 53.37  
High school 256 36.73  
GED 33 4.73  
AA and above 36 5.16  
 
   
GAD at intake    
No 435 62.77  
Yes 258 37.23  
 
The first independent variable for the study is divided into two composite scores, 
ASI alcohol composite score (items acs_0 to acs_16 of the assessment) and ASI drug 
composite score (items dcs_asi_0 to dcs_asi_16 of the assessment). Both of these items 
are scores from 0 to 1. The ASI alcohol composite score is derived from questions 
embedded within the assessment that ask days of alcohol use, days of alcohol use to 
intoxication, days bothered by alcohol problems, how troubled the participant is by 
alcohol problems, the importance of treating these problems, and amount of money spent 
on alcohol. The ASI drug composite score is derived from questions regarding days of 
heroin, methadone, other opiate, barbiturate, other sedative, cocaine, amphetamine, 
cannabis, and hallucinogen use; days of using more than one substance in a day; days of 
problems from drug use; how troubled by these problems; and how important to get 
treatment for these problems (Scott, Dennis, Laudet, & Simeone, 2011). There is not a 
cutoff score above which is high severity and below which is low severity; however, the 
closer the score is to the value 1, the higher the severity score.  
The alcohol and drug composite scores were measured repeatedly throughout, and 
the mean values were calculated at intake, Year 6, and during the final wave at Year 16 
(see Table 2). At intake the alcohol composite score had a mean of 0.21 with a standard 
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deviation of 0.28 and the drug composite score had a mean of 0.26 with a standard 
deviation of 0.13. At Year 6 the alcohol score had a new lower mean of 0.08 with a 
standard deviation of 0.14, indicating some improvement, and the drug abuse score had a 
lower mean of 0.08 with a standard deviation of 0.11, also indicating improvement in the 
drug abuse composite score. At Year 6, generalized anxiety disorder was now present in 
only 18.3% (n = 106) of the sample as opposed to the 24% at intake, thus indicating that 
as the rates of GAD decreased over time, so did the alcohol and drug composite scores. 
  
Table 2. Alcohol and drug composite scores   
   
Variable N Mean/ 
Standard deviation 
Intake   
Alcohol Abuse Score (mean) 697 M = 0.21, SD = 0.28 
Drug Abuse Score (mean) 697 M = 0.21, SD = 0.28 
   
Year 6   
Alcohol Abuse Score (mean) 644 M = 0.08, SD = 0.14 
Drug Abuse Score (mean) 644 M = 0.08, SD = 0.11 
   
Year 16   
Alcohol Abuse Score (mean) 577 M = 0.05, SD = 0.11 
Drug Abuse Score (mean) 577 M = 0.06, SD = 0.11 
 
The severity of the anxiety scores, derived from the Anxiety Fear Symptom Scale 
(AFSS), was also calculated for the first time during the Year 6 wave: 84.6% of the 
sample had mid anxiety-fear symptom scores (rating 0–3), 13.3% had moderate (rating 
4–7) scores, and only 2% had severe (rating 8–10) scores.  
 
 
  
 
62
 
Table 3. Severity of anxiety/fear symptoms and GAD  
  
Variable N Percentage Mean/ 
Standard deviation 
Individual characteristics at Year 6    
 
   
Severity of anxiety/fear symptoms    
Mid (0–3) 489 84.6  
Moderate (4–7) 77 13.32  
Severe (8–10) 12 2.08  
 
   
Table 3 (cont.)    
 
   
GAD    
No 471 81.6  
Yes 106 18.34  
 
   
Individual characteristics at Year 16    
 
   
Severity of anxiety/fear symptoms    
Mid (0–3) 472 81.66  
Moderate (4–7) 74 12.80  
Severe (8–10) 32 5.54  
 
   
GAD    
No 487 84.4  
Yes 90 15.6  
 
SURVIVAL ANALYSIS AND COX REGRESSION ANALYSIS 
Research Question #1: How prevalent is generalized anxiety disorder among African 
American women aged 18+? 
 
 At intake, 697 women were analyzed, and 37% (n = 258) of this sample reported 
having GAD. This is significantly higher than what is reported in the general population; 
however, this is right in line with the percent of those with both substance use and 
anxiety disorders. GAD is present in 3.1% of the population in any given year, though 
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women are twice as likely to be affected as men and it affects 30% of people with 
substance use disorders. 
 
Research Question #2: What is the relationship between anxiety and drug use in this 
population?  
 
 Within this study population, GAD and the alcohol and drug composite scores 
had a direct relationship. As the incidence of GAD decreased over time, so did the 
severity of the ASI alcohol and drug composite scores. 
 
Research Question #3: Are there any differences in the level of education and the 
relationship between substance use and abuse to GAD? 
 
There were no significant differences in the level of education and rates of GAD 
and the severity of anxiety-fear symptoms. Almost half of the sample had no degree 
while the other half had a high school diploma or higher. None of the variables proved to 
be significant when education was predicted to moderate this relationship.    
 
Research Question #4: Is one possible motive for the drug use and abuse to alleviate 
anxiety symptoms?  
 
This question does seem to be supported. As the rates of alcohol and drug use 
decreased, as evidenced by the decreasing alcohol and drug composite scores, the rates of 
GAD also decreased. One possible reason for this is that drugs were used to alleviate the 
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symptoms from anxiety, but without a causal relationship determination, it is hard to say 
with certainty that this is the case. It is also plausible that the inverse is true and the 
anxiety disorder was a product of the substance abuse and as the substance abuse issues 
decreased, so did the anxiety surrounding the disorder.  
 
Hypothesis #1: As a participant becomes free of substance use disorder (SUD) their rates 
of GAD will increase.  
 
It was hypothesized that as the alcohol and drug composite scores decreased, the 
incidence of GAD would increase. This hypothesis was not supported. As the study went 
on, the alcohol and drug composite scores decreased as did the incidence of GAD. First, 
at intake, 258 (37.23%) participants had GAD; at Year 6, 106 (18.34%) were still 
diagnosed with GAD, while at Year 16 only 90 (15.60%) still reported symptoms that 
allowed for a diagnosis of GAD. Similarly, both the alcohol and drug composite scores 
decreased in this same time period. At intake the alcohol and drug composite score means 
were 0.21 (+/- 0.28) and 0.26 (+/- 0.13), respectively. At Year 6 the alcohol composite 
scores had decreased to a mean of 0.08 (+/- 0.14) and the drug composite scores were 
also 0.08 (+/- 0.11). Finally, at the last wave of data analyzed, Year 16, the alcohol and 
drug composite scores were 0.05 and 0.06, respectively. As time progressed the incidence 
of GAD decreased and the alcohol and drug composite scores also decreased, indicating 
less severe issues in these two areas. 
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Hypothesis #2: A study participant’s rates of GAD will be inversely related to rates of 
SUD.   
 
It was hypothesized that the relationship between GAD and SUD was inversely 
related (as one increased, the other would decrease), but this was incorrect. As the study 
went on, the alcohol and drug composite scores decreased as did the incidence of GAD, 
thus instead indicating a direct relationship between the variables. 
 
Hypothesis #3: Coping skills are also moderating factors on the relationship between 
GAD and SUD.  
 
As originally hypothesized, coping skills did not act as a moderating factor. The 
results of the analysis did not support the hypothesis that coping skills were a moderating 
factor on GAD, the severity of anxiety symptoms, and SUD, since none of the terms 
proved significant.  
High perceived family support acted as a protective factor for both GAD and the 
severity of anxiety symptoms. This was not the case with moderate to high perceived 
social support or even moderate perceived family support. Although family support 
protected against GAD, none of the interaction terms between substance use and family 
and social support were significant, indicating absence of moderating effect.  
Hazard ratios for the onset of GAD in survival analysis are presented in Table 4. 
Cox proportional hazard models with time-dependent covariates were used to calculate 
hazard ratios (HR). Severe alcohol composite scores and severe drug composite scores 
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increased the likelihood of GAD sooner as well as having higher scores on the Anxiety 
Fear Symptom Scale (HR = 1.75; CI = 1.34–2.28 p < 0.001 and HR = 2.15; CI = 1.49–
3.12 p < 0.001, respectively). Being dually diagnosed and having some criminal justice 
charges or involvement were both associated with an increased risk for generalized 
anxiety disorders over time (HR = 1.46; CI = 1.04–2.05 p = 0.028 and HR = 1.27; CI = 
1.02–1.60 p = 0.034, respectively). There were no significant findings in terms of 
perceived social or family support regardless of the level of perception (low, moderate, or 
high). Age, insurance type, religion, homelessness, dependent children, public aid, age of 
first drug use, employment status, and highest level of education received provided no 
level of significance in determining whether these control variables have an effect on 
GAD prevalence. 
 
Table 4. Estimated hazard ratios for onset of GAD in survival analysis  
  
Variable Hazard 
ratio 
95% 
confidence 
interval 
P-value 
Alcohol score    
0 Reference Reference Reference 
Moderate 1.18 0.88–1.58 0.263 
Severe 1.75 1.34–2.28 < 0.001 
    
Drug score    
0 Reference Reference Reference 
Moderate 1.27 0.89–1.81 0.194 
Severe 2.15 1.49–3.12 < 0.001 
    
Perceived social support    
Low Reference Reference Reference 
Moderate 0.98 0.75–1.27 0.877 
High 0.97 0.72–1.31 0.850 
    
Perceived family support    
Low Reference Reference Reference 
Moderate 1.01 0.77–1.33 0.924 
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Table 4 (cont.) 
 
High 
 
 
0.801 
 
 
0.60–1.07 
 
 
0.132 
    
Age 1.02 0.99–1.04 0.083 
    
Insurance    
Uninsured Reference Reference Reference 
Medicaid 04 0.94 0.70–1.26 0.678 
Else 1.04 0.74–1.45 0.836 
    
Religion    
None Reference Reference Reference 
Protestant 1.21 0.85–1.73 0.283 
All else 1.21 0.75–1.96 0.444 
    
Homeless    
No Reference Reference Reference 
Yes 0.95 0.75–1.21 0.680 
    
Dependent children    
No Reference Reference Reference 
Yes 0.88 0.68–1.14 0.324 
    
Dually diagnosed    
No Reference Reference Reference 
Yes 1.46 1.04–2.05 0.028 
    
Criminal justice charged    
No Reference Reference Reference 
Yes 1.27 1.02–1.60 0.034 
    
Receiving public aid    
No Reference Reference Reference 
Yes 0.85 0.66–1.09 0.196 
    
Age first used drugs    
≤ 12 0.863 0.59–1.27 0.457 
13–17 Reference Reference Reference 
18–24 1.00 0.78–1.29 0.986 
≥ 25 0.724 0.50–1.05 0.088 
    
Employment status    
Not employed Reference Reference Reference 
Full-time 1.23 0.89–1.69 0.217 
Part-time 0.991 0.59–1.67 0.975 
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Table 4 (cont.) 
 
Else 
 
 
0.736 
 
 
0.43–1.26 
 
 
0.267 
    
Highest degree received    
None Reference Reference Reference 
High school 0.81 0.63–1.05 0.105 
GED 1.23 0.68–2.18 0.512 
AA and above 0.726 0.44–1.21 0.222 
    
Model specifics    
Number of person: 537    
Number of person-years observation: 2117    
 
For computing odds ratios and for regression analyses, the comparison group for 
the alcohol and drug composite scores is composed of those who had a composite alcohol 
or drug score of 0. Low social support and low family support were used as a reference 
group for those categories. Being uninsured, having no religious affiliation, not being 
homeless, having no dependent children, having no dual diagnosis, and having no 
criminal charges were also used as reference models for the respective categories. 
Additionally, not being on public aid, being unemployed, and not having some type of 
degree were also used. Finally, the age group of 13–17 years was used as a reference 
when calculating age odds and hazard ratios.  
Risk for GAD among African American women was not significant by age. The 
odds ratios (OR) for individual mixed-effects regressions on incidence of GAD in 
relation to alcohol and drug use are presented in Table 5. Factors that increase the 
likelihood of GAD prevalence over time are severe alcohol composite scores (OR = 2.00; 
CI = 1.52-2.66 p = 0.001), both moderate (OR = 1.53; CI = 1.14-2.06 p = 0.004) and 
severe (OR = 3.94; CI = 2.90-5.35 p < 0.001) drug composite scores, and being dually 
diagnosed (OR = 2.27; CI = 1.49-3.45 p < 0.001). It was also demonstrated that high 
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perceived family support acts as a protective factor for GAD with an odds ratio of 0.61 
(CI = 0.43-0.87) and a significance level of p = 0.007. No statistically significant 
association was found between GAD prevalence and any level of perceived social 
support, age, any type of insurance, religious affiliation, homelessness, dependent 
children, criminal justice charges, receiving public aid, age of first use of drugs, 
employment status, or level of education received. 
 
Table 5. Results from individual mixed-effects regressions on incidence of GAD 
 
Variable Odds 
ratio 
95% 
confidence 
interval 
P-value 
Alcohol score    
0 Reference Reference Reference 
Moderate 1.24 0.95–1.62 0.120 
Severe 2.00 1.52–2.66 0.001 
    
Drug score    
0 Reference Reference Reference 
Moderate 1.53 1.14–2.06 0.004 
Severe 3.94 2.90–5.35 < 0.001 
    
Perceived social support    
Low Reference Reference Reference 
Moderate 1.01 0.72–1.19 0.95 
High 0.97 0.67–1.40 0.87 
    
Perceived family support    
Low Reference Reference Reference 
Moderate 0.81 0.57–1.15 0.24 
High 0.61 0.43–0.87 0.007 
    
Age 1.01 0.99–1.04 0.332 
    
Insurance    
Uninsured Reference Reference Reference 
Medicaid 04 0.98 0.70–1.26 0.911 
Else 1.32 0.74–1.45 0.229 
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Table 5 (cont.) 
 
Religion 
None Reference Reference Reference 
Protestant 1.00 0.85–1.73 0.985 
All else 1.20 0.75–1.96 0.524 
    
Homeless    
No Reference Reference Reference 
Yes 1.04 0.770–1.40 0.816 
    
Dependent children    
No Reference Reference Reference 
Yes 0.83 0.59–1.16 0.266 
 
Dually diagnosed 
   
No Reference Reference Reference 
Yes 2.27 1.49–3.45 < 0.001 
    
Criminal justice charged    
No Reference Reference Reference 
Yes 1.19 0.90–1.58 0.222 
    
 
   
Receiving public aid    
No Reference Reference Reference 
Yes 1.02 0.74–1.42 0.884 
    
Age first used drugs    
≤ 12 0.76 0.47–1.23 0.267 
13–17 Reference Reference Reference 
18–24 0.93 0.67–1.29 0.658 
≥ 25 0.64 0.40–1.04 0.069 
    
Employment status    
Not employed Reference Reference Reference 
Full-time 1.33 0.90–1.97 0.152 
Part-time 0.88 0.50–1.55 0.655 
Else 0.63 0.32–1.26 0.191 
    
Highest degree received    
None Reference Reference Reference 
High school 0.92 0.68–1.25 0.61 
GED 1.19 0.61–2.33 0.62 
AA and above 0.87 0.47–1.60 0.66 
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Table 5 (cont.) 
 
Model specifics 
   
Number of person: 537    
Number of person-years observation: 3556    
LR test vs. single-level logistic regression ( ) 119.70  < 0.001 
 
Hazard ratios for anxiety-fear symptoms in survival analysis are presented in 
Table 6. Using the Anxiety Fear Symptom Scale (10 items), a cutoff score of 4 was used 
to indicate individuals who needed some level of treatment for their anxiety. Moderate 
alcohol (HR = 1.48; CI = 1.06-2.06 p = 0.02) composite scores and both moderate (HR = 
1.59; 1.10-2.28 p = 0.013) and severe (HR = 3.73; CI = 2.59-5.37 p < 0.001) drug 
composite scores increased the likelihood of having higher scores on the Anxiety Fear 
Symptom Scale. Moderate alcohol use proved significant only in terms of increasing the 
likelihood of having higher anxiety scores requiring treatment. Having some type of 
insurance other than Medicaid (HR = 1.86; CI = 1.27-2.75 p 0.002) also increased the 
likelihood of high anxiety-fear symptom scores sooner. This may be attributed to the fact 
that those with some type of private health insurance were more likely to go to the doctor 
to have their anxiety symptoms assessed and thus receive a diagnosis. Being dually 
diagnosed increased the likelihood of having more severe anxiety-fear symptom scores 
with an earlier onset and a hazard ratio of 1.57 (CI = 1.05-2.34 p 0.029). 
 
Table 6. Estimated hazard ratios for onset of the severity of anxiety symptoms in 
survival analysis 
  
Variable Hazard ratio 95% confidence 
interval 
P-value 
Alcohol score    
0 Reference Reference Reference 
Moderate 1.48 1.06–2.06 0.020 
Severe 1.32 0.92–1.92 0.136 
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Table 6 (cont.) 
 
Drug score 
   
0 Reference Reference Reference 
Moderate 1.59 1.10–2.28 0.013 
Severe 3.73 2.59–5.37 < 0.001 
    
Perceived social support    
Low Reference Reference Reference 
Moderate 0.97 0.70–1.34 0.841 
High 0.86 0.61–1.21 0.386 
    
Perceived family support    
Low Reference Reference Reference 
Moderate 1.06 0.75–1.50 0.752 
High 0.80 0.57–1.14 0.214 
    
Age 0.99 0.97–1.02 0.617 
    
Insurance    
Uninsured Reference Reference Reference 
Medicaid 04 1.04 0.73–1.49 0.815 
Else 1.86 1.27–2.75 0.002 
 
   
Religion    
None Reference Reference Reference 
Protestant 0.95 0.61–1.50 0.839 
All else 0.84 0.46–1.54 0.578 
    
Homeless    
No Reference Reference Reference 
Yes 1.12 0.84–1.51 0.445 
    
Dependent children    
No Reference Reference Reference 
Yes 0.89 0.64–1.23 0.469 
    
Dually diagnosed    
No Reference Reference Reference 
Yes 1.57 1.05–2.34 0.029 
    
Criminal justice charged    
No Reference Reference Reference 
Yes 1.12 0.85–1.47 0.437 
    
 
   
  
 
73
Table 6 (cont.) 
 
Receiving public aid 
No Reference Reference Reference 
Yes 0.95 0.69–1.31 0.742 
    
Age first used drugs    
≤ 12 0.69 0.41–1.15 0.151 
13–17 Reference Reference Reference 
18–24 0.905 0.66–1.25 0.542 
≥ 25 0.89 0.58–1.35 0.573 
    
Employment status    
Not employed Reference Reference Reference 
Full-time 0.808 0.54–1.21 0.306 
Part-time 0.79 0.40–1.56 0.489 
Else 0.86 0.44–1.67 0.651 
 
Highest degree received 
   
None Reference Reference Reference 
High school 0.83 0.61–1.14 0.250 
GED 0.96 0.51–1.81 0.892 
AA and above 1.20 0.69–2.08 0.520 
    
 
Model specifics    
Number of person: 537    
Number of person-years observation: 2401   
 
Odds ratios for individual mixed-effects regressions on the severity of anxiety 
symptoms in relation to alcohol and drug use are presented in Table 7. Having both 
moderate and severe alcohol composite scores, severe and moderate drug composite 
scores, some type of private insurance (not including Medicaid), and being dually 
diagnosed increased the risk for having higher anxiety-fear symptom scores, indicating 
that some level of treatment is needed. Again, here it was demonstrated that high 
perceived family support acted as a protective factor and decreased the risk for more 
severe anxiety-fear symptoms.  
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Table 7. Results from individual mixed-effects regressions on severity of anxiety 
symptoms 
 
Variable Odds 
ratio 
95% 
confidence 
interval 
P-value 
Alcohol score    
0 Reference Reference Reference 
Moderate 1.59 1.06–2.06 0.008 
Severe 1.75 0.92–1.92 0.004 
    
Drug score    
0 Reference Reference Reference 
 
Moderate 
2.10 1.10–2.28 < 0.001 
Severe 5.47 2.59–5.37 < 0.001 
    
Perceived social support    
Low Reference Reference Reference 
Moderate 1.07 0.70–1.34 0.766 
High 0.89 0.70–1.25 0.643 
 
Perceived family support    
Low Reference Reference Reference 
Moderate 0.75 0.75–1.50 0.228 
High 0.56 0.57–1.14 0.018 
    
Age 0.99 0.97–1.02 0.741 
    
Insurance    
Uninsured Reference Reference Reference 
Medicaid 04 1.03 0.63–1.69 0.910 
Else 2.29 0.63–1.69 0.006 
    
Religion    
None Reference Reference Reference 
Protestant 0.93 0.51–1.68 0.807 
All else 0.91 0.42–1.97 0.813 
    
Homeless    
No Reference Reference Reference 
Yes 1.10 0.73–1.65 0.645 
    
Dependent children    
No Reference Reference Reference 
Yes 0.83 0.53–1.32 0.436 
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Table 7 (cont.) 
 
   
Dually diagnosed    
No Reference Reference Reference 
Yes 2.49 0.42–4.35 0.001 
    
Criminal justice charged    
No Reference Reference Reference 
Yes 1.24 0.85–1.81 0.274 
    
Receiving public aid    
No Reference Reference Reference 
Yes 1.06 0.69–1.65 0.789 
    
Age first used drugs    
≤ 12 0.71 0.36–1.38 0.308 
13–17 Reference Reference Reference 
18–24 1.01 0.65–1.56 0.981 
≥ 25 0.74 0.38–1.42 0.363 
    
Employment status    
Not employed Reference Reference Reference 
Full-time 0.79 0.45–1.39 0.406 
Part-time 0.73 0.32–1.65 0.446 
Else 0.71 0.29–1.72 0.442 
    
Highest degree received    
None Reference Reference Reference 
High school 0.74 0.49–1.13 0.160 
GED 0.73 0.28–1.91 0.517 
AA and above 0.96 0.43–2.16 0.919 
    
Model specifics    
Number of persons: 537    
Number of person-years observation: 3201    
LR test vs. single-level logistic regression ( ) 148.71  < 0.001 
 
SIGNIFICANT PROTECTIVE FACTORS 
Only high (and not low or moderate) perceived family support was shown to be a 
protective factor in terms of the mixed-effects regression analysis of GAD as well as the 
severity of anxiety-fear symptoms. 
  
 
76
SIGNIFICANT FACTORS THAT INCREASE THE LIKELIHOOD OF GAD 
The following factors proved to be significant in increasing the likelihood of 
GAD incidence or having more severe anxiety-fear symptoms: being dually diagnosed 
across all models, some level of moderate to severe drug and alcohol composite scores, 
criminal justice charges, and having some type of insurance that did not include 
Medicaid.  
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CHAPTER 5 
DISCUSSION 
 
 
 
This study examined the link between generalized anxiety disorder, severity of 
anxiety-fear symptoms, and drug use disorders as well as the moderating effects of 
coping skills by focusing on issues that were frequently unaddressed in previous studies. 
Among the issues addressed in this study were the influence of comorbidity and gender 
and demographic correlates on this proposed link.  
The present analyses suggest that 1) high perceived family support is a protective 
factor against GAD over a 10-year period; 2) high perceived family support is a 
protective factor against severe anxiety symptoms (that indicate treatment is necessary) 
over a 10-year period; 3) factors that increase the likelihood of GAD incidence are severe 
alcohol composite scores, severe and moderate drug composite scores, and being dually 
diagnosed; 4) factors that increase the likelihood of earlier onset of GAD are severe 
alcohol composite scores, severe drug composite scores, criminal justice charges or 
involvement, and being dually diagnosed; 5) factors that increase the likelihood of more 
severe anxiety symptoms (that indicate treatment is necessary) are both moderate and 
severe alcohol composite scores, severe and moderate drug composite scores, having 
some type of private insurance that is not Medicaid, and being dually diagnosed; 6) 
factors that increase the likelihood of developing severe anxiety symptoms requiring 
treatment sooner are moderate alcohol composite scores, severe and moderate drug 
composite scores, having some type of private insurance that is not Medicaid, and being 
dually diagnosed. 
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Individuals have biological and psychological characteristics that can make them 
either more vulnerable or more resilient to potential behavioral health problems (Nasim, 
Fernander, Townsend, Corona, & Belgrave, 2011). Protective factors are “events, 
conditions, or experiences that reduce, inhibit, or attenuate the likelihood of substance 
use or deviant behaviors to occur” (Hawkins, Catalano, & Miller, 1992). Protective 
factors occur over many levels, including community, cultural, familial, and individual 
(Nasim, Fernander, Townsend, Corona, & Belgrave, 2011).  
Below is a chart created by the National Institute on Drug Abuse (Robertson, 
David, & Rao, 2003) that looks at five dimensions that affect African American youth 
and how those dimensions are affected by either risk factors or protective factors: 
 
Risk Factors Domain Protective Factors 
Early Aggressive Behavior Individual Self-Control 
Lack of Parental Supervision Family Parental Monitoring 
Substance Abuse Peer Academic Competence 
Drug Availability School Anti–Drug Use Policies 
Poverty Community Strong Neighborhood Attachment 
 
As outlined above, some examples of community-level protective factors for 
African Americans include strong neighborhood attachment, intergenerational networks, 
and available community resources (Nasim, Fernander, Townsend, Corona, & Belgrave, 
2011). One possible cultural protective factor is religious beliefs and practices shared by 
many African Americans.  
Individual-level protective factors might include a positive self-image, self-
confidence, or perceived social competence (Nasim, Fernander, Townsend, Corona, & 
Belgrave, 2011). Having high self-esteem has been found to act as a protective factor 
  
 
79
against depression and anxiety in African American youth (Dumont & Provost, 1999). 
Individual factors also include social and problem-solving skills, a positive attitude, a 
positive temperament, and high intelligence or academic achievement (Jenson & Fraser, 
2005). There were no major differences found in the current study data with regards to 
level of education. The majority of this sample, 53% (n = 372), reported having no degree 
at all, while only 5% (n = 36) had some type of degree above a high school diploma or 
GED. 
Familial protective factors include parental and family members’ support and a 
high family cohesion (Nasim, Fernander, Townsend, Corona, & Belgrave, 2011). Family 
member support has been shown to produce a reduction in negative outcomes, 
particularly externalizing problems. The results of the present study also reflect current 
literature on family support as a protective factor in the African American community. 
Perceived social support has been shown to play a buffering role between stress 
and psychological well-being (Cohen & Wills, 1985). Social support can be described as 
“the frequency of contact with others; the resources that people perceive as available or 
that are actually provided; and the perceived adequacy of that support from both formal 
and informal sources” (Cohen, Underwood, & Gottlieb, 2000). Social networks represent 
the links between individuals and includes the emotional assistance one receives from 
friends, family, and significant others (Thoits, 1995). Previous literature on perceived 
social support has documented that familial and peer social support are differentially 
related to outcomes and therefore should be evaluated independently (Lyons, Perrotta, & 
Hancher-Kvam, 1988), as can also be demonstrated with the results of the current study. 
Perceived social support had no effect as a significant factor, while perceived family 
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support displayed a tremendous effect. The results also demonstrate the importance of 
discriminating between family and friends support, which is consistent with previous 
findings. Antonucci and Israel (1986) reported that the social support between an 
individual was higher for family members than it was for friends, and social support also 
varied by what was deemed the “closeness” of the relationship.  
Having high perceived family support provided protective factors for both GAD 
and the severity of anxiety-fear symptoms. Family therapy as a treatment for substance 
abuse has grown in popularity and acceptance over the past two decades (Thoits, 1995). 
Researchers have reported that addiction often develops within a family context and can 
be maintained or worsened by family interaction (Thoits, 1995). The family thus has a 
central role to play in the treatment of any health problem, including substance abuse and 
mental health issues (Thoits, 1995). A primary challenge in incorporating a family 
component into treatment remains the idea that the substance abuse treatment focus is on 
the individual and not the family structure as a whole (Thoits, 1995). Family can play a 
large and complex role in substance abuse treatment. They can be a source of help to the 
treatment process. The results of this study indicate a need to engage and provide services 
to the whole family in order to improve treatment effectiveness and outcomes of the 
substance user as well as those suffering from anxiety disorders. 
The results of this study also go on to strengthen the body of literature that 
already exists surrounding the importance of family functioning and parental support as 
protective factors against substance use and misuse (Thoits, 1995). This research also 
expands on these previous findings by examining this influence over a period of 16 years. 
Additional research also suggests that families play a central role in the well-being of 
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relatives with co-occurring mental and substance-use disorders through direct care, 
financial assistance, and emotional support (Clark, 2001; Clark & Drake, 1994). 
Individuals in this study fared well even if they merely perceived that they had high 
family support. It is important to note that low to moderate family support did not prove 
significant in protecting against GAD or severe anxiety-fear symptoms. All of this seems 
to makes sense, since the alcohol and drug problems of individuals also affect their 
families and the afflicted may feel responsible (Thoits, 1995). 
Moderate to severe alcohol and drug use composite scores were shown to increase 
the likelihood of GAD incidence as well as the severity of anxiety-fear symptom scores. 
These results fall right in line with the current literature. These scores were calculated 
using the Addiction Severity Index (ASI; McLellan, Luborsky, O’Brien, & Woody, 1980; 
McLellan et al., 1992), or ASI. The ASI is one of the most widely used assessment 
instruments in the substance abuse field. The ASI has demonstrated high inter-rater 
reliability (McLellan, Luborsky, Cacciola, & Griffith, 1985). It is often used by 
researchers in studies of treatment outcome and as a clinical assessment tool in numerous 
treatment facilities throughout the country (McLellan et al., 1992). One of the summary 
indices used in the ASI is the composite scores. The composite scores (CSs) are summary 
indices used by clinical staff in substance use at intake and at follow-up evaluations to 
determine past 30-day severity in all seven of the problem areas: medical status, 
employment and support, drug use, alcohol use, legal status, family and social status, and 
psychiatric status (McLellan et al., 1992). Composite scores are mathematically sound 
measures of change in regards to the problem status. The composite scores can be used to 
compare the individual’s results at the beginning of treatment and at subsequent follow-
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up sessions to monitor improvement or lack of improvement since the last evaluation 
(McLellan et al., 1992). 
The ASI composite scores are weighted summary scores determined on a defined 
set of items in each of the problem areas. The composite scores range in severity from 0 
(no problem) to 1 (most severe). Since the CSs include only items that are subject to 
change (occurrence in past 30 days or during the follow-up period), they have been 
recommended for use in treatment outcome studies whose focus is on change (McLellan 
Luborsky, Cacciola, & Griffith, 1985). The results here decreased over time. As can be 
seen from Table I, both the alcohol and drug composite scores decreased significantly 
from the intake to 6-month evaluations and then again even lower at Year 16. 
It is important to note that there is a bit of controversy surrounding the ASI 
scores. The primary issue is that the composite scores are not standardized, so equivalent 
scores in different problem areas cannot be assumed to be indicative of equivalent 
problem severity; however, this issue does not pose a problem to this data. The overall 
analysis looks at the change in scores over time (Keller & Craske, 2008). 
As previously stated above, it has been estimated that 50–60% of women entering 
substance abuse treatment have a co-occurring mental disorder (Newmann & Sallmann, 
2004). The results of this study indicate that being dually diagnosed has negative effects 
on both GAD and severity of anxiety-fear symptoms. This variable was deemed 
significant across all models.  
Women with co-occurring disorders report higher levels of physical, sexual, and 
emotional victimization than women in general as well as men. Women with co-
occurring disorders also have a greater likelihood of adverse health (Brady & Randall, 
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1999; Chander & McCaul, 2003) and social outcomes (DiNitto, Webb, & Rubin, 2002). 
When neither illness is treated, one illness can make the other worse. When only one 
illness is treated, treatment is less likely to be effective. When both illnesses are treated, 
the chances for a full and lasting recovery are greatly improved, and it is easier to return 
to a full and productive life. This would indicate a serious need to incorporate multiple 
levels of treatment that would work on issues and not just simply address the substance 
use. It also outlines the importance of developing gender-specific interventions.  
Currently, there are three prominent views concerning the link between mental disorders 
such as depression and anxiety disorders and drug use disorders (Kushner, Abrams, & 
Borchardt, 2000). The first two views, the self-medication hypothesis and the onset and 
worsening of mental disorder symptoms resulting from drug use, are considered causal 
explanations involving direct and indirect reasons for the link between mental disorders 
and drug use disorders (Kessler & Price, 1993). The third view, shared etiology, posits 
that mental and drug use disorders are not causally linked. Instead, there is a third 
variable that is causally linked to both. 
The self-medication hypothesis states that individuals with psychiatric disorders 
will use substances to relieve psychiatric symptoms and that this pattern of usage 
predisposes them to addiction (Khantzian, 1985). The preferred substance is not random 
but instead is based on the unique properties of the substance. For example, someone 
suffering from anxiety would prefer alcohol use to amphetamines because of the 
alcohol’s anxiolytic (antianxiety) characteristics (Khantzian, 1985). A key implication of 
this model is that treating the underlying psychiatric disorder will resolve the addictive 
disorder (Khantzian, 1985). 
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It is hypothesized that oftentimes people may use alcohol or drugs to help cover 
up, mask, or alleviate the symptoms of a mood disorder (Thoits, 1995). This is deemed 
“self-medication” and it may appear to help, but it tends to make the problems worse. 
After the temporary effects of the alcohol or drugs wear off, a person’s symptoms are 
often worse than ever. Self-medication also can cause a person’s mood disorder to stay 
undiagnosed for a long time because the effects are masked by the use of the substances. 
Therefore, there is an endless cycle of negative emotions followed by alcohol or drug use, 
which only alleviates the symptoms for a short while. Once the symptoms return, the 
individual again wants to use to fight or help suppress those emotions. Since the alcohol 
and drug composite scores and the rates of GAD also decreased during the same time 
period, the idea of self-medication might not be too far off the mark. However, this study 
still does not provide a causal link between substance abuse and GAD or the severity of 
anxiety symptoms; therefore, more research is necessary to determine which disorder 
occurred first and then treat as necessary. This study evidence does strongly reinforce the 
idea that substance use and GAD are linked. 
The current results do not support a causal relation between the initial onset of an 
anxiety disorder and drug use disorders. Anxiety disorders and drug use disorders may 
have a mutually reinforcing relationship (Drake, Mueser, & Brunette, 2007). A greater 
risk for drug abuse or dependence associated with comorbid disorders may indicate a 
tendency for individuals with multiple disorders to have a drug use disorder among their 
disorders. Either substance abuse or mental illness can develop first (Drake, Mueser, & 
Brunette, 2007). The results of this study do not explain whether one disease causes the 
other. A person experiencing a mental health condition may turn to drugs and alcohol as a 
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form of self-medication to improve the troubling mental health symptoms they 
experience. Additionally, the use of drugs and alcohol may make the symptoms of mental 
health conditions worse. Abusing substances can also lead to mental health problems 
because of the effects drugs have on a person’s moods, thoughts, brain chemistry, and 
behavior (Substance Abuse and Mental Health Services Administration [SAMHSA], 
2004). Therefore, further research is needed to determine the causal pathway of these two 
disorders. 
Having some type of insurance (not including Medicaid) increased the onset of more 
severe anxiety symptoms. One possible explanation for this could be the fact that individuals 
with some type of insurance are more likely to receive medical treatment and thus be 
diagnosed with severe anxiety symptoms that may require treatment. This is right in line with 
the current thought on health insurance. Current research literature has associated both 
continuous and comprehensive insurance coverage with better health outcomes for both 
children and adults when it makes health care affordable (Baker, Sudano, Albert, 
Borawski, & Dor, 2002; Hsia et al., 2000). Adults with continuous insurance coverage 
are healthier and at lower risk for premature death than those who are uninsured or whose 
coverage is intermittent, while children with continuous coverage are more likely to visit 
a doctor, receive preventive care, and have prescriptions filled (Baker, Sudano, Albert, 
Borawski, & Dor, 2002; Hsia et al., 2000). Specifically, looking at the coverage of mental 
health services, adults with health insurance that includes mental health services are more 
likely to receive mental health treatment that is consistent with proposed medical 
guidelines. When people are uninsured or underinsured while also suffering from a 
mental illness, they tend to rely heavily on emergency room services, with significant 
costs to the community (Hsia et al., 2000). 
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As can be expected, uninsured people generally receive much less care, either 
preventive or for acute and chronic conditions, than insured people. In particular, 
uninsured adults report lower levels of self-perceived wellness and functioning. The 
negative aspects of this are the simple fact that undiagnosed and untreated illnesses and 
conditions can result in costs to both individuals and society (Hsia et al., 2000). The lack 
of adequate health insurance, especially in terms of mental health benefits, can create 
financial barriers that jeopardize the utilization of appropriate care.  
Finally, as previously stated, coping skills did not act as a moderating variable 
between GAD and the severity of the anxiety symptoms. None of the variable terms 
proved to be significant. Several recent studies have begun to look at individuals’ coping 
skills in order to determine the relationship between coping ability and health behaviors. 
These types of coping behaviors are typically divided into two categories: healthy 
(active), or adaptive coping, and unhealthy, or avoidant or maladaptive coping. The 
coping strategies included in the Pathways assessment include both healthy and active 
coping strategies and maladaptive coping strategies. For example, several questions ask 
whether the participant has “sought help from persons or groups with the same type of 
problems” or “thought about how you were much better off than other people with 
similar problems.” The few avoidant strategies listed included such items as “tried not to 
think about the problem” and “tried to forget about the whole thing.” It would be 
interesting to further research the specific types of coping strategies that are used with 
individuals suffering from GAD and substance use–related issues. 
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CHAPTER 6 
CONCLUSION 
 
 
IMPLICATIONS 
 
Findings from this study have several potential implications for prevention and 
treatment of mental and drug use disorders. Given the limited funds often available for 
substance use treatment and mental health intervention efforts, targeting populations that 
are specifically at risk would be of the most importance.  
Very little research exists that specifically relates to the effectiveness of treatment 
interventions designed for women who abuse substances (Fillmore et al., 1997). 
However, some research shows that gender-specific interventions seem to be more 
effective than traditional mixed-gender interventions (Koos, Brand, Rojas, & Li, 2014). 
Gender-specific treatment includes but is not limited to gender-matching with counselors, 
gender-specific treatment groups, and mixed-gender treatment groups led by male and 
female co-leaders that have gender-specific treatment content (Fillmore et al., 1997). 
The prevalence of comorbidity between anxiety disorders and drug use disorders 
is higher among females than males (Compton, Cottler, Phelps, Ben Abdallah, & 
Spitznagel, 2000). Taken together, findings concerning gender differences in the 
prevalence of mental and drug use disorders suggest that sex variations may be found in 
the risk significance of psychiatric disorders for drug use disorders. This has greater 
implications in terms of indicating a need for more targeted treatment programs geared 
toward these issues in women. 
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Women substance-abusers have unique characteristics, such as having a later 
initiation, typically also having a comorbid problem, and substance abuse problems 
interfering with functioning in more areas of life than men. There is a further need for 
research studies to incorporate these differences when designing and implementing 
treatment programs specifically designed for women. The barriers that women face in 
seeking treatment include availability, accessibility, affordability, and acceptability. More 
research is needed in this area as well so that these barriers can be overcome and 
treatment can be more effective.  
Effective substance abuse prevention and treatment for girls and women requires 
creating programs that will address the specific risks and consequences of substance use 
that are more frequently associated with females. As demonstrated by this study, over 
half of the African American women surveyed (52%) reported being 13–17 years old 
when they first used drugs. This is important because it shows a potential age range that 
would seem to benefit most from preventative drug education. Screening and brief 
interventions have been found to be effective in reducing alcohol consumption and 
potentially reducing the risk of alcohol abuse and dependence in adolescents (Babor & 
Kadden, 2005). The prevention programs that have proven most effective have included 
school-based educational programs, family-based programs, and mass media 
programming. Using this information, it might be effective to utilize both school 
counselors and family doctors to screen and deliver these brief interventions. 
Many traditional treatment programs do not allow for the inclusion of children, 
leaving a woman to decide between the need to care for her children and the need for 
substance abuse treatment. Potential involvement with the child welfare system also 
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complicates a woman’s decision to seek care because admitting to a substance abuse 
problem may lead to involvement with the criminal justice system or the loss of custody 
of children (Fillmore et al., 1997). Currently, there are several family-based treatment 
programs that demonstrate that families do not need to be separated for them to achieve 
success in treatment and recovery. 
The demonstrated link between the co-occurrence of anxiety disorders and drug 
use disorders underscores the importance of tailoring treatment efforts to address 
multilevel factors in treatment. Designing culturally sensitive interventions are 
particularly important for interventions aimed at minorities. Interventions that have 
proven successful in targeting minority women are typically culturally specific, recruit 
staff who are bilingual and ethnically compatible with the target group, and form close 
relationships with the community that these women reside in (Clark, 2001; Clark & 
Drake, 1994). The findings from this study suggest that individuals with multiple 
disorders are clearly at the greatest risk for having drug use problems. These findings also 
indicate that having a dual diagnosis suggests a more severe problem than does either a 
substance use or mental health disorder alone.  
These results also underscore the importance of treating female African American 
substance users with programs that are tailored to their female needs in addition to 
consideration of their race. Interventions and prevention efforts should be tailored to the 
target population and address contextual issues such as culture.  
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LIMITATIONS 
The results of this study should be interpreted with caution because of its 
limitations. As previously outlined, the participants from this study were all African 
American females and confined to the Chicago, Illinois area. The uniqueness of the study 
within a specific geographical context makes it difficult to replicate fully in another 
setting and to say with confidence that the sample chosen will be representative of the 
population as a whole. Because of potential limitations in the generalizability of the 
findings obtained with this study, the present results should be replicated in samples 
drawn from the general population.  
Second, all the assessment waves were administered using an interviewer and thus 
required the participants to self-report. With self- report comes a couple potential pitfalls. 
Individuals may exaggerate symptoms in order to make their situation seem worse, or, in 
contrast, they may underreport the severity or frequency of symptoms in order to 
minimize their problems and to please the interviewer. The participants might also simply 
be mistaken or misremember the information requested. Patients might also simply be 
mistaken or misremember the information requested. 
One additional ethical issue and potential limitation that is important to discuss is 
the idea of paying the participants to participate. Paying incentives often facilitates 
recruitment, helps make participation a revenue-neutral experience, and allows for 
compensation for time and contribution (Scott, Foss, & Dennis, 2005). It is reasonable to 
pay someone for their work. However, since many of these women were still using drugs 
throughout the study, the incentive money might actually be used to further their drug 
use. In turn, the act of providing cash to drug users as part of this longitudinal study 
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might influence the outcomes being measured. Another issue with paying for 
participation is the fact that it may result in a skewed sample. Money may be more 
attractive to lower-income individuals and thus skew the sample to those of a lower 
socioeconomic status. 
 Additionally, the main variables of the anxiety-fear symptoms began to be 
assessed only within the Year 6 wave of this study. One problem often encountered with 
longitudinal data is missing or incomplete data. Measuring participants repeatedly over 
time may lead to repeated opportunities for missing data, either through failure to answer 
certain items, missed assessments, or permanent withdrawal from the study; however, in 
this case the issue was with the addition of new items later in the study. It would provide 
a better picture if the severity of anxiety-fear symptoms were also taken at intake and 
then again each year the study was conducted. There is also a gap from Year 10 until 
Year 15 when funding for the study lapsed. It would be interesting to have data from 
those years to provide a clearer picture of the trajectory of GAD and anxiety-fear 
symptoms. 
A final limitation of previous studies as well as this current study is the lack of 
attention to temporal order (Chilcoat & Breslau, 1998a, 1998b). There was no 
information collected about the order of the onset of substance use or GAD; it is possible 
that one disorder preceded the other, which would prove highly advantageous in 
implementing methods to combat these comorbid disorders. By not specifically looking 
at the order of the onset of mental and drug use disorders, it is impossible to determine 
the direction of risk, which is necessary to assess causality (Chilcoat & Breslau, 1998a, 
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1998b). Therefore, the question still remains whether anxiety disorders place individuals 
at increased risk for drug use disorders or whether the reverse is true. 
 
CONCLUSION 
This study used a longitudinal secondary analysis design, which can be useful in 
examining lifetime prevalence, including cohort differences, but is problematic for the 
definitive identification of causal links (Rogosa, 1979). Longitudinal designs are best 
suited for examining such causal links and making recommendations for future studies 
(Boslaugh, 2007). Despite findings suggesting that differences across ethnicity may be 
involved in the link between mental and drug use disorders, this was not the focus of the 
present study, since only African American female participants were analyzed. Future 
studies examining contextual variables such as the influence of culture on risk for drug 
use disorder initiation are suggested as well as research on mental health stigma by this 
population. Since African Americans in general do not present in mental health care 
settings (National Institutes of Mental Health, 2013), care should be taken to familiarize 
them with the services available in order to increase service utilizations. For example, to 
help overcome the negative stereotypes and stigmas associated with mental health, an 
outreach campaign might help to present accurate images of those who can benefit from 
such services (Williams, Domanico, Marques, Leblanc, & Turkheimer, 2013). 
Furthermore, this study demonstrated the importance of family support within the context 
of mental health and substance abuse disorders. By acknowledging the importance of 
supportive relationships with families, professional providers of mental health 
interventions should join forces with these sources of informal support in order to provide 
a better and potentially more effective program. 
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As discussed above, African American women experience double minority status 
where their identity of being both African American and a woman affects them in a way 
that is greater than the sum of the independent effects of those identities (Crenshaw, 
1989; Crenshaw, 1991). This idea is often interchangeably used with the term, 
intersectionality even though the terms do not carry quite the same meaning.  
Intersectionality is used to describe the intersecting effects of race, class, gender, sexual 
orientation and other marginalizing characteristics that contribute to social identity and 
affect one’s health (Crenshaw, 1989; Crenshaw, 1991; Seng, Lopez, Sperlich, Hamama, 
& Reed Meldrum, 2012). Kimberlé Crenshaw perfectly described this phenomenon as it 
relates to the current population, African American women, in 1989: 
“[Black women] sometimes experience discrimination in ways similar to White 
women’s experiences; sometimes they share very similar experiences with Black 
men. Yet often they experience double discrimination-- the combined effects of 
practices which discriminate on the basis of race, and on the basis of sex. And 
sometimes, they experience discrimination as Black women-- not the sum of race 
and sex discrimination, but as Black women (p. 149).” 
  Typically, studies focus on explaining inequalities by examining only a single 
demographic factor, such as sex, race, or socioeconomic status, and these attempts fall 
short of adequately explaining health disparities (Carbado & Gulati, 2013).  
 Considering intersectionality in studying African American women with 
substance use and anxiety disorders will help to combat the limitations of research that 
focus on pre-determined classifications such as gender or one single category (race, class, 
etc.) within a contextual analysis. 
  
 
94
FUTURE RESEARCH 
Anxiety is one of the most commonly occurring psychiatric disorders. 
It occurs more frequently in females than in males and is often associated with difficulty 
in social, academic, or vocational functioning. For many individuals the onset of anxiety 
occurs early in life and takes a chronic course. This presents a significant problem 
because anxiety disorders may cause considerable distress for individuals, including 
impairment in social and vocational functioning. If left untreated, anxiety disorders may 
play a significant role in the development or exacerbation of other psychiatric disorders, 
including depression and substance abuse, and they are often associated with a variety of 
medical illnesses (Starcevic, 2005). At this time most of the current research concerning 
the onset, etiology, and treatment for anxiety disorders has focused on populations with 
no regard to race, ethnicity, or gender. Relatively little is known about the course of 
anxiety and its treatment in African American females. More research is needed 
regarding the prevalence rates, onset, and etiology of anxiety disorders specifically within 
this population. Advancing the knowledge on this topic would lead to more public 
education and possibly more effective treatments methods designed for African American 
women. Current psychiatric literature clearly indicates that early intervention often leads 
to a better treatment prognosis in terms of anxiety disorders. 
Finally, current research indicates that there is a rise in anxiety disorders 
attributable to a range of factors. Anxiety rates have risen steadily over the past seven 
decades, during both good economic times and bad. “There is a sense that the world is 
not as safe as it used to be, and that creates a lot of anxiety” (Dreisbach, 2010).  
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It is also notable that while these disorders are commonly found in a comorbid 
state and have generated a great deal of focused research attention independently, further 
studies are necessary in order to determine how to adequately treat comorbid anxiety and 
substance use disorders.  
Additionally, intersectionality has been well-defined, often through Black 
feminist teachings (Crenshaw, 1989; Crenshaw, 1991); however, approaches to modeling 
the construct in quantitative studies of health outcomes are still lacking (Seng, et al., 
2012; Carbado & Gulati, 2013). Most studies interested in exploring intersectionality 
have attempted to do so by simply noting demographic characteristics as representation 
of structural inequalities (Seng, et al., 2012). In order to combat this, Seng et al (2012) 
attempted to look at intersectionality across four levels: structural, contextual, and 
interpersonal and intrapersonal. Future research could utilize this method attempted by 
Seng & colleagues (2012), and examine these four levels. Analyses that focus solely on 
gender, race, or class independently are insufficient in adequately describing health care 
inequalities as these social positions are experienced simultaneously by African 
American women. While intersectionality has become more prevalent in the sociological 
study of gender, it is rarely applied to other areas of research. By incorporating use of 
intersectionality into health outcomes for African American women, this could 
potentially provide a framework for moving from individual-level conceptualizations of 
these women, to structural examinations that take into account dimensions of race, class, 
and gender, as well as how these dimensions shape health inequities. These studies will 
prove to enhance the understanding of the etiological and maintaining factors in these 
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comorbid conditions as well as improve the ability to treat individuals suffering from 
these conditions. 
 
 
  
 
97
REFERENCES 
 
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental 
disorders (4th ed.). Washington, DC: Author.  
Antonucci, T. C., & Israel, B. A. (1986). Veridicality of social support: A comparison of 
principal and network members’ responses. Journal of Consulting and Clinical 
Psychology, 54, 432–437. 
Babor, T. F., & Kadden, R. M. (2005). Screening and interventions for alcohol and drug 
problems in medical settings: What works? Journal of Trauma, 59, S80–S87. 
Baker, D., Sudano, J., Albert, J., Borawski, E., & Dor, A. (2002). Loss of health 
insurance and the risk for decline in self-reported health and physical functioning. 
Medical Care, 40(11), 1126–1131. 
Barlow D. H. (Ed.) (2001). Clinical handbook of psychological disorders (3rd ed.). New 
York: Guilford Press. 
Barlow, D. H. (2004). The experience of anxiety: Shadow of intelligence or specter of 
death? In D. H. Barlow (Ed.), Anxiety and its disorders (2nd ed., pp. 1–36). New 
York: Guilford Press. 
Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in 
social psychological research: Conceptual, strategic, and statistical considerations. 
Journal of Personality and Social Psychology, 51, 1173–1182.  
Behar, E., DiMarco, I. D., Heckler, E. B., Mohlman, J., & Staples, A. M. (2009). Current 
theoretical models of generalized anxiety disorder (GAD): Conceptual review and 
treatment implications. Journal of Anxiety Disorders, 23, 1011–1023, 
  
 
98
Blood, E. A., Cabral, H., Heeren, T., & Cheng, D. M. (2010). Performance of mixed 
effects models in the analysis of mediated longitudinal data. BMC Medical 
Research Methodology, 10(2). doi:10.1186/1471-2288-10-16 
Borkovec, T. D., & Costello, E. (1993). Efficacy of applied relaxation and cognitive-
behavioral therapy in the treatment of generalized anxiety disorder. Journal of 
Consulting and Clinical Psychology, 61(4), 611–619. doi:10.1037/0022-
006X.61.4.611 
Borkovec, T. D., Lyonfields, J. D., Wiser, S. L., & Deihl, L. (1993). The role of 
worrisome thinking in the suppression of cardiovascular response to phobic 
imagery. Behaviour Research and Therapy, 31(3), 321–324.  
Boslaugh, S. (2007). Secondary data sources for public health: A practical guide. 
Cambridge: Cambridge University Press. 
Brady, K. T., & Randall, C. L. (1999). Gender differences in substance use 
disorders. Psychiatric Clinics of North America, 22, 241–252. 
Brady, T. M., & Ashley, O. S. (Ed.) (2005). Women in substance abuse treatment: 
Results from the Alcohol and Drug Services Study (ADSS) (DHHS Pub. No. SMA 
04–3968, Analytic Series A–26). Rockville, MD: Substance Abuse and Mental 
Health Services Administration, Office of Applied Studies. 
Brecht, M. L., O’Brien, A., Von Mayrhauser, C., & Anglin, M. D. (2004). 
Methamphetamine use behaviors and gender differences. Addictive Behaviors, 
29(1), 89–106. 
Breslau, J., Kendler, K., Maxwell, S. U., Gaxiola-Aguilar, S., & Kessler, R. C. (2005). 
Lifetime risk and persistence of psychiatric disorders across ethnic groups in the 
  
 
99
United States. Psychological Medicine, 35(3), 317–327. 
doi:10.1017/S0033291704003514 
Buchman, D. Z., Skinner, W., & Illes, J. (2010). Negotiating the relationship between 
addiction, ethics, and brain science. AJOB Neuroscience, 1(1), 36–45. 
doi:10.1080/21507740903508609 
Campbell, R. J. (2009). Psychiatric dictionary (9th ed.). New York: Oxford University 
Press. 
Carbado, D. W., & Gulati, M. (2013). The Intersectional Fifth Black Woman. Du Bois 
Review: Social Science Research On Race, 10(2), 527-540. 
doi:10.1017/S1742058X13000301. 
Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in 
the United States: Results from the 2014 National Survey on Drug Use and 
Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved 
from http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-
2014/NSDUH-FRR1-2014.pdf 
Chan, Y.-F., Dennis, M. L., & Funk, R. R. (2008). Prevalence and comorbidity of major 
internalizing and externalizing problems among adolescentes and adults 
presenting to substance abuse treatment. Journal of Substance Abuse Treatment, 
34(1), 14–24. 
Chander, G., & McCaul, M. E. (2003). Co-occurring psychiatric disorders in women with 
addictions. Obstetrics and Gynecology Clinics of North America, 30, 469–481. 
Chilcoat, H. D., & Breslau, N. (1998a). Investigations of causal pathways between PTSD 
and drug use disorders. Addictive Behavior, 23, 827–840. 
  
 
100
Chilcoat, H. D., & Breslau, N. (1998b). Posttraumatic stress disorder and drug disorders. 
Archives of General Psychiatry, 55(10), 913–917. 
Clark, R. E. (2001). Family support and substance use outcomes for persons with mental 
illness and substance use disorders. Schizophrenia Bulletin, 27(1), 93–101. 
Clark, R. E., & Drake, R. E. (1994). Expenditure of time and money by families of 
people with severe mental illness and substance use disorder. Community Mental 
Health Journal, 30(2), 145–163. 
Clark, T. T., Corneille, M., & Coman, E. (2013). Developmental trajectories of alcohol 
use among monoracial and biracial black adolescents and adults. Journal of 
Psychoactive Drugs, 45(3), 249–257. doi:10.1080/02791072.2013.805980 
Cohen, S., Underwood, L. G., & Gottlieb, B. H. (2000). Social relationships and health. 
In S. Cohen, L. G. Underwood, & B. H. Gottlieb (Eds.), Social support 
measurement and intervention: A guide for health and social scientists (pp. 3–25). 
New York: Oxford University Press. 
Cohen, S., & Wills, T. A. (1985) Stress, social support, and the buffering hypothesis. 
Psychological Bulletin, 98, 310–357. 
Collins, P.H. (2000). Black Feminist Thought: Knowledge, Consciousness, and the 
Politics of Empowerment (Revised Tenth Anniversary Edition), 2nd ed. New 
York: Routledge. 
Compton, W. M., Cottler, L. B., Phelps, D. L., Ben Abdallah, A., Spitznagel, E. L. 
(2000). Psychiatric disorders among drug dependent subjects: Are they primary or 
secondary? American Journal of Addiction, 9(2), 126–134. 
  
 
101
Cook, T. O., & Campbell, D. T. (1979). Quasi-experimentation: Design and analysis. 
Chicago: Rand-McNally. 
Cortis, N. (2012) Overlooked and under-served? Promoting service use and engagement 
among “hard-to-reach” populations. International Journal of Social Welfare, 
21(4), 351 - 360. 
Cox, D. R., & Oakes, D. (1984). Analysis of survival data. London: Chapman and Hall. 
Craske, M. G. (2003). Origins of phobias and anxiety disorders: Why more women than 
men? Oxford: Elsevier. 
Craske, M. G., & Chowdhury, N. (2005). Introduction: Why are women anxious and 
worried more often than men? In H. Hazlett-Stevens (Auth.), Women who worry 
too much: How to stop worry & anxiety from ruining relationships, work & fun 
(pp. 1–10). Oakland: New Harbinger. 
Crenshaw, K. (1989). Demarginalizing the intersection of race and sex: a Black feminist 
critique of antidiscrimination doctrine, feminist theory and antiracist politics.  
University of Chicago Legal Forum, 139, 139e167. 
Crenshaw, K. (1991). Mapping the Margins: Intersectionality, Identity Politics, and 
Violence Against Women of Color. Stanford Law Review, 43: 1241–1299. 
De Graaf, R., Bijl, R. V., Smit, F., Vollebergh, W. A., & Spijker, J. (2002). Risk factors 
for 12-month comorbidity of mood, anxiety, and substance use disorders: 
Findings from the Netherlands Mental Health Survey and Incidence Study. The 
American Journal of Psychiatry, 159(4), 620–629. 
  
 
102
Dennis, M. L., Foss, M. A., & Scott, C. K. (2007). An eight-year perspective on the 
relationship between the duration of abstinence and other aspects of recovery. 
Evaluation Review, 31, 585–612. doi:10.1177/0193841X07307771 
Dennis, M. L., Scott, C. K, Funk, R., & Foss, M. A. (2005). The duration and correlates 
of addiction and treatment careers. Journal of Substance Abuse Treatment, 
28(Suppl. 1), S51–S62. doi:10.1016/j.jsat.2004.10.013 
Dennis, M. L., Scott, C. K, & Funk, R. (2003). An experimental evaluation of recovery 
management checkups (RMC) for people with chronic substance use disorders. 
Evaluation and Program Planning, 26, 339–352. 
DiNitto, D. M., Webb, D. K., & Rubin A. (2002). Gender differences in dully-diagnosed 
clients receiving chemical dependency treatment. Journal of Psychoactive Drugs, 
34, 105–117. 
Drake, R. E., Mueser, K. T., Brunette, M. F. (2007). Management of persons with co- 
occurring severe mental illness and substance use disorders: Program 
implications. World Psychiatry, 6(3), 131–136. 
Drapela, L. A. (2006). The effect of negative emotion on licit and illicit drug use among 
high school dropouts: An empirical test of general strain theory. Journal of Youth 
and Adolescence, 35(5), 752–767. 
Dreisback, S. (2010, October 15). Why are anxiety disorders among women on the rise? 
NBCNews.com. Retrieved from http://www.nbcnews.com/id/39335628/ns/health-
mental_health/t/why-are-anxiety-disorders-among-women-
rise/#.VmGzWWSfrGc 
  
 
103
Dumont, M., & Provost, M. A. (1999). Resilience in adolescents: Protective role of social 
support, coping strategies, self-esteem, and social activities on experience of 
stress and depression. Journal of Youth and Adolescence, 28(3), 343–363. 
Elmir, R., Schmied, V., Jackson, D., & Wilkes, L. (2011) Interviewing people about 
potentially sensitive topics. Nurse Researcher, 19(1), 12–16. 
Faugier, J., & Sargeant, M. (1997). Sampling hard to reach populations. Journal of 
Advanced Nursing, 26(4), 790–797. 
Feske, U., Tarter, R. E., Kirisci, L., Gao, Z., Reynolds, M., & Vanyukov, M. (2008). Peer 
environment mediates parental history and individual risk in the etiology of 
cannabis use disorder in boys: A 10-year prospective study. American Journal of 
Drug & Alcohol Abuse, 34(3), 307–320.  
Fillmore, K. M., Golding, J. M., Leino, E. V., Motoyoshi, M., Shoemaker, C., & Terry, 
H. (1997). Patterns and trends in women’s and men’s drinking. In R. W. Wilsnack 
& S. C. Wilsnack (Eds.), Gender and alcohol: Individual and social perspectives 
(pp. 21–48). New Brunswick, NJ: Center of Alcohol Studies, Rutgers University. 
Flores, E., Tschann, J., Dimas, J., Bachen, E., Pasch, L., & de Groat, C. (2008). Perceived 
discrimination, perceived stress, and mental and physical health among Mexican-
origin adults. Hispanic Journal of Behavioral Sciences, 30(4), 401–424. 
Garner, B. R., Scott, C. K, Dennis, M. L., & Funk, R. R. (2014). The relationship 
between recovery and health-related quality of life. Journal of Substance Abuse 
Treatment, 47(4), 293–298. 
  
 
104
Gonzales, P. M., Blanton, H., & Williams, K. J. (2002). The effects of stereotype threat 
and double-minority status on the test performance of Latino women. Personality 
and Social Psychology Bulletin, 28(5), 659–670. 
Goodwin, R. D., Fergusson, D. M., & Horwood, L. J. (2004). Association between 
anxiety disorders and substance use disorders among young persons: Results of a 
21-year longitudinal study. Journal of Psychiatric Research, 38(3), 295–304. 
Green, C. A. (2006). Gender and use of substance abuse treatment services. Alcohol 
Research & Health, 29(1), 55–62. 
Greer, Tawanda M. (2011). Coping strategies as moderators of the relation between 
individual race-related stress and mental health symptoms for African American 
women. Psychology of Women Quarterly, 35(2), 215–226. 
Harris, T. L., & Molock, S. D. (2000). Cultural orientation, family cohesion, and family 
support in suicide ideation and depression among African American college 
students. Suicide and Life-Threatening Behavior, 30(4), 341–353. 
Hawkins, D., Catalano, R., & Miller, J. (1992). Risk and protective factors for alcohol 
and other drug problems in adolescence and early adulthood. Psychological 
Bulletin, 112(1), 64–105. 
Himle, J. A., Baser, R. E., Taylor, R., Campbell, R., & Jackson, J. S. (2009). Anxiety 
disorders among African Americans, blacks of Caribbean descent, and non-
Hispanic whites in the United States. Journal Of Anxiety Disorders, 23(5), 578–
590. doi:10.1016/j.janxdis.2009.01.002 
Hosmer, D. W., Lemeshow, S., & May, S. (2008). Applied survival analysis: Regression 
modeling of time to event data (2nd ed.). Hoboken, NJ: Wiley. 
  
 
105
Hsia, J., Kemper, E., Kiefe, C., Zapka, J., Sofaer, S., Pettinger, M., & Women’s Health 
Initiative Investigators. (2000). The importance of health insurance as a 
determinant of cancer screening: Evidence from the Women’s Health 
Initiative. Preventive Medicine, 31(3), 261–270. 
Institutional Review Board (2014). Institutional review board for the protection of human 
subjects. University of Illinois at Champaign-Urbana. Retrieved from 
http://oprs.research.illinois.edu  
Jenson, J. M., & Fraser, M. W. (2006). A risk and resilience framework for child, youth, 
and family policy. In J. M. Jenson and M. W. Fraser (Eds.), Social policy for 
children and families: A risk and resilience perspective (pp. 1–18). Thousand 
Oaks, CA: Sage. 
Keller, M. L., & Craske, M. G. (2008). Panic disorder and agoraphobia. In J. Hunsley & 
E. J. Mash (Eds.), A guide to assessments that work (pp. 229–253). New York: 
Oxford University Press. 
Kessler, R. C., Chiu, W., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and 
comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey 
Replication. Archives of General Psychiatry, 62(6), 617–627. 
doi:10.1001/archpsyc.62.6.617 
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. 
J. (1996). The epidemiology of co-occurring addictive and mental disorders: 
Implications for prevention and service utilization. American Journal of 
Orthopsychiatry, 66, 154–166. 
  
 
106
Kessler, R. C., & Price, R. H. (1993). Primary prevention of secondary disorders: A 
proposal and agenda. American Journal of Community Psychology, 21(5), 607–
633. 
Khalsa, J. H., Treisman, G., McCance-Katz, E., & Tedaldi, E. (2008). Medical 
consequences of drug abuse and co-occurring infections: Research at the National 
Institute on Drug Abuse. Substance Abuse: Official Publication of the Association 
for Medical Education and Research in Substance Abuse, 29(3), 5–16. 
Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: Focus on 
heroin and cocaine dependence. American Journal of Psychiatry, 142(11), 1259–
1264.  
Koos, E., Brand, M., Rojas, J., & Li, J. (2014). Sex-specific substance abuse treatment for 
female healthcare professionals: Implications. Southern Medical Journal, 107(1), 
28–33. doi:10.1097/SMJ.0000000000000049 
Kushner, M. G., Abrams, K., & Borchardt, C. (2000). The relationship between anxiety 
disorders and alcohol use disorders: A review of major perspectives and findings. 
Clinical Psychology Review, 20, 149–171. 
Kushner, M. G., Sher, K. J., & Beitman, B. D. (1990). The relation between alcohol 
problems and the anxiety disorders. American Journal of Psychiatry, 147(6), 685–
95. 
Kushner, M. G., Sher, K. J., & Erickson,  D. J. (1999). Prospective analysis of the 
relation between DSM-III anxiety disorders and alcohol use disorders. American 
Journal of Psychiatry, 156, 723–732. 
  
 
107
Lopez, B., Turner, R. J., & Saavedra, L. M. (2005). Anxiety and risk for substance 
dependence among late adolescents/young adults. Journal of Anxiety Disorders, 
19, 275–294. doi: 10.1016/j.janxdis.2004.03.001 
Lyons, J. S., Perrotta, P., & Hancehr-Kvan, S. (1988). Perceived social support from 
family and friends: Measurement across disparate samples. Journal of Personality 
Assessment, 52(1), 42–47. 
McGovern, M. P., Xie, N., Segal, S. R., Siembab, L., & Drake, R. E. (2006). Addiction 
treatment services and co-occurring disorders: Prevalence estimates, treatment 
practices, and barriers. Journal of Substance Abuse Treatment, 31(3), 267–275. 
McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., . . . 
Argeriou, M. (1992). The fifth edition of the Addiction Severity Index. Journal of 
Substance Abuse Treatment, 9, 199–213.  
McLellan, A. T., Luborsky, L., Cacciola, J., & Griffith, J. E. (1985). New data from the 
Addiction Severity Index: Reliability and validity in three centers. The Journal of 
Nervous and Mental Disease, 173, 412–423.  
McLellan, A. T., Luborsky, L., O’Brien, C. P., & Woody, G. E. (1980). An improved 
evaluation instrument for substance abuse patients: The Addiction Severity Index. 
The Journal of Nervous and Mental Disease, 168, 26–33. 
McNeece, C. A., & DiNitto, D. M. (2012). Chemical dependency: A systems approach 
(4th ed.). Boston: Allyn and Bacon. 
Miller, W. R., & Carroll, K. M. (2006). Drawing the science together: Ten principles, ten 
recommendations. In W. R. Miller and K. M. Carroll (Eds.), Rethinking substance 
  
 
108
abuse: What the science shows, and what we should do about it (pp. 293–311). 
New York: Guilford Press. 
Nasim, A., Fernander, A., Townsend, T. G., Corona, R., & Belgrave, F. Z. (2011). 
Cultural protective factors for community risks and substance use among rural 
African American adolescents. Journal of Ethnicity in Substance Abuse, 10(4), 
316–336. doi:10.1080/15332640.2011.623510 
National Institutes of Mental Health. (2013). Anxiety disorders. Retrieved from 
http://www.nimh.nih.gov/health/topics/anxiety-disorders/index.shtml  
Neal-Barnett, A., & Crowther, J. (2000). To be female, middle class, anxious, and black. 
Psychology of Women Quarterly, 24(2), 129–136. 
Newmann, J. P., & Sallmann, J. (2004). Women, trauma histories, and co-occurring 
disorders: Assessing the scope of the problem. Social Service Review, 78(3), 466–
499.  
Padwa, H., Larkins, S., Crevecoeur-Macphail, D. A., & Grella, C. E. (2013). Dual 
diagnosis capability in mental health and substance use disorder treatment 
programs. Journal of Dual Diagnosis, 9(2), 179–186. 
doi:10.1080/15504263.2013.778441 
Rapee, R. M., & Barlow, D. H. (2001). Generalized anxiety disorders, panic disorders, 
and phobias. In H. E. Adams & P. B. Sutker (Eds.), Comprehensive handbook of 
psychopathology (3rd ed.). New York: Springer. 
Robertson, E. B., David, S. L., & Rao, S. A. (2003). Preventing drug use among children 
and adolescents (in brief). Washington, DC: National Institute on Drug Abuse. 
  
 
109
Roemer, L., Orsillo, S. M., & Barlow, D. H. (2002). Generalized anxiety disorder. In D. 
H. Barlow (Ed.), Anxiety and its disorders (2nd ed., pp. 477–515). New York: 
Guilford Press. 
Rogosa, D. (1979). Causal models in longitudinal research: Rationale, formulation, and 
interpretation. In J. R. Nesselroade & P. B. Baltes (Eds.), Longitudinal research 
in the study of behavior and development (pp. 263–302). New York: Academic 
Press. 
Sadler, G. R., Lee, H., Lim, R. S., & Fullerton, J. (2010). Recruitment of hard-to-reach 
population subgroups via adaptations of the snowball sampling strategy. Nursing 
& Health Sciences, 12(3), 369–374. doi:10.1111/j.1442-2018.2010.00541.x 
Sanderson, K., & Andrews, G. (2002). Prevalence and severity of mental health related 
disability and relationship to diagnosis. Psychiatric Services, 53, 80–86. 
Scott, C. K. (2004). A replicable model for achieving over 90% follow-up rates in 
longitudinal studies of substance abusers. Drug and Alcohol Dependence, 74, 21–
36. doi:10.1016/j.drugalcdep.2003.11.007 
Scott, C. K, Dennis, M. L., Laudet, A., Funk, R. R., & Simeone, R. S. (2011). Surviving 
drug addiction: The effect of treatment and abstinence on mortality. American 
Journal of Public Health, 101, 737–744. doi:10.2105/AJPH.2010.197038 
Scott, C. K, Foss, M. A., & Dennis, M. L. (2005). Pathways in the relapse-treatment-
recovery cycle over 3 years. Journal of Substance Abuse Treatment, 28(Suppl. 1), 
S63–S72. doi:10.1016/j.jsat.2004.09.006 
Scott, C. K, Foss, M. A. & Sherman, R. E. (2003a). Effects of centralized intake on 
participant satisfaction with treatment and ancillary services. In R. C. Stephens, C. 
  
 
110
K Scott, & R. D. Muck (Eds.), Clinical assessment and substance abuse 
treatment: The target cities experience (pp. 149–64). Albany: State University of 
New York Press. 
Scott, C. K., Foss, M. A. & Sherman, R. E. (2003b.) Outcomes before and after 
implementing centralized intake services. In R. C. Stephens, C. K Scott, & R. D. 
Muck (Eds.), Clinical assessment and substance abuse treatment: The target 
cities experience (pp. 7–15). Albany: State University of New York Press. 
Scott, C. K, Much, R. D., & Foss, M. A. (2000). The impact of centralized intake on 
access to treatment and satisfaction with intake procedures. In J. A. Levy, R. C. 
Stephens, and D. C. McBride (Eds.), Advances in medical sociology, Vol. 7: 
Emergent issues in the field of drug abuse (pp. 131–50). Stamford, CT: JAI Press. 
Scott, C. K, Sonis, J., Creamer, M., & Dennis, M. L. (2006). Maximizing follow-up in 
longitudinal studies of traumatized populations. Journal of Traumatic Stress, 19, 
757–769. doi: 10.1002/jts.20186 
Seng, J. S., Lopez, W. D., Sperlich, M., Hamama, L., & Reed Meldrum, C. D. (2012). 
Marginalized identities, discrimination burden, and mental health: Empirical 
exploration of an interpersonal-level approach to modeling intersectionality. 
Social Science & Medicine, 75(12), 2437-2445. 
doi:10.1016/j.socscimed.2012.09.023 
Sloboda, Z., Glantz, M. D., & Tarter, R. E. (2012). Revisiting the concepts of risk and 
protective factors for understanding the etiology and development of substance 
use and substance use disorders: Implications for prevention. Substance Use & 
Misuse, 47(8–9), 944–962.  
  
 
111
Starcevic, V. (2005). Anxiety disorders in adults: A clinical guide. New York: Oxford 
University Press. 
Substance Abuse and Mental Health Services Administration. (2001). Summary of 
findings from the 2000 National Household Survey of Drug Abuse. Rockville, 
MD: Department of Health and Human Services.  
Substance Abuse and Mental Health Services Administration. (2004). The NSDUH 
Report: Adults with co-occurring serious mental illness and a substance use 
disorder. Rockville, MD: US Department of Health and Human Services. 
Substance Abuse and Mental Health Services Administration. (2009). The NSDUH 
Report: Treatment for substance use and depression among adults, by 
race/ethnicity. Rockville, MD: Author. 
Substance Abuse and Mental Health Services Administration. (2011). The Dual 
Diagnosis Capability in Addiction Treatment (DDCAT) toolkit. Retrieved from 
http://www.samhsa.gov/co-occurring/DDCAT/index.html 
Thoits, P. A. (1995). Stress, coping, and social support processes: Where are we? What 
next? Forty years of medical sociology: The state of the art and directions for the 
future [Special issue]. Journal of Health & Social Behavior, 35(Suppl. 1), 53–79. 
Thom, B. (1987). Sex differences in help-seeking for alcohol problems—2. Entry into 
treatment. British Journal of Addiction, 82, 989–997. 
U.S. Census Bureau. (1999). Statistical abstracts of the United States: The national data 
book. Washington, DC: Author. 
  
 
112
Vorspan, F., Mehtelli, W., Dupuy, G., Bloch, V., & Lépine, J. (2015). Anxiety and 
substance use disorders: Co-occurrence and clinical issues. Current Psychiatry 
Reports, 17(2), 4. 
Ward, E. C., Clark, L., & Heidrich, S. (2009). African American women’s beliefs, coping 
behaviors, and barriers to seeking mental health services. Qualitative Health 
Research, 19(11), 1589–1601. doi:10.1177/1049732309350686 
Watson, D., & Clark, L. A. (1984).  Negative affectivity: The disposition to experience 
aversive emotional states. Psychological Bulletin, 96(3), 465–490. 
doi:10.1037//0033-2909.96.3.465  
Williams, M., Domanico, J., Marques, L., Leblanc, N., & Turkheimer, E. (2012). Barriers 
to treatment among African Americans with obsessive-compulsive disorder. 
Journal Of Anxiety Disorders, 26(4), 555–563. 
Williamson, K. (2015). Some things cannot be separated: intersectionality in the lives of 
black women activists in Salvador, Brazil, African and Black Diaspora: An 
International Journal, 8:1, 86-101, DOI: 10.1080/17528631.2014.972702. 
Wittchen, H. U. (2002). Generalized Anxiety Disorder: Prevalence, Burden, and Cost to 
Society. Depression & Anxiety, 16, 162–171. 
Wittchen, H. U., Perkonigg, A., & Reed, V. (1996). Comorbidity of mental disorders and 
substance use disorders. European Addiction Research, 2, 36–47. 
Woodward, A. T., Taylor, R. J., Bullard, K. M., Neighbors, H. W., Chatters, L. M., & 
Jackson, J. S. (2008). Use of professional and informal support by African 
Americans and Caribbean Blacks with mental disorders. Psychiatric Services, 
59(11), 1292–1298. 
  
 
113
Zvolensky, M. J., Lejuez, C. W., & Eifert, G. H. (2000). Prediction and control: 
Operational definitions for the experimental analysis of anxiety. Behavior 
Research and Therapy, 38, 653–663. 
  
 
114
APPENDIX A: IRB APPROVAL LETTER 
 
The approval letter from the University of Illinois Institutional Review Board may be found 
in a supplemental file named IRB Letter-12-15-2014. 
  
 
115
APPENDIX B: PATHWAYS ASSESSMENT 
 
The questionnaire used to gather all of the data that has been presented in this dissertation 
may be found in a supplemental file named pathways_ 1 04. 
 
